Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.7990157130658894,-2.0258473480308763,0.0,0.038669440764119434,0.037,9/12,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE4B;PDE2A
prerank,amino acid:sodium symporter activity (GO:0005283),-0.810161340798967,-2.0171091609778897,0.0,0.02086114567538022,0.04,7/11,14.33%,SLC1A3;SLC6A13;SLC6A12;SLC1A2;SLC1A1;SLC6A1;SLC6A15
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6323446960393445,-2.012438414641175,0.0,0.016621075416156598,0.045,20/29,22.74%,GRIK2;GRID2;GABRG3;GRIA2;GABRB1;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GLRA3;GLRA2;GABRB2;GABRA1;GABRE;GRIA4;GRIK5;GABRB3;CHRNB1
prerank,phosphatidate phosphatase activity (GO:0008195),0.8649702190680186,1.933100144378308,0.0,0.31971362262105146,0.236,1/13,0.01%,PLPPR2
prerank,cAMP binding (GO:0030552),-0.7671380885586804,-1.9040360595530001,0.002506265664160401,0.05800416114617915,0.192,7/11,9.95%,RAPGEF2;PDE4D;PDE4A;PDE10A;PDE4B;CNBD2;PDE2A
prerank,lipid phosphatase activity (GO:0042577),0.8477726183438675,1.8619730913331138,0.0015527950310559005,0.5351728030830645,0.545,1/14,0.01%,PLPPR2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.7386370283267736,-1.8525673516857197,0.0,0.08222344246686447,0.308,4/11,10.65%,SASH1;DAB2IP;ROR2;TRAF6
prerank,platelet-derived growth factor binding (GO:0048407),-0.7669274534655515,-1.833246391804995,0.0,0.08598862485705507,0.366,6/11,3.97%,PDGFRB;COL1A2;COL1A1;COL5A1;PDGFRA;COL4A1
prerank,C-C chemokine receptor activity (GO:0016493),0.7730715594580758,1.8275273885330081,0.005934718100890208,0.5911061387175962,0.732,8/21,6.17%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;GPR75
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7353618999494541,-1.8062076013627502,0.0025575447570332483,0.09870883563472592,0.462,4/11,4.78%,KCNK2;KCNT2;KCND2;PKD2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.7167642487665065,-1.8055031211443933,0.0,0.08687903961149201,0.464,10/13,19.24%,GABRG3;GLRA1;GABRG2;GABRG1;GABRA3;GLRA3;GLRA2;GABRA1;GLRB;GABRE
prerank,chemokine receptor activity (GO:0004950),0.7359227352974836,1.780614368758583,0.0071633237822349575,0.7290364205264194,0.879,8/24,6.17%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;GPR75
prerank,tropomyosin binding (GO:0005523),0.8072638604212081,1.7790352280348731,0.00909090909090909,0.5909737521243784,0.88,6/16,5.09%,CALD1;NEBL;TMOD3;S100A6;TMOD2;LMOD3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6703711714325482,-1.7733912297788188,0.0027548209366391185,0.1099026211190763,0.581,5/14,9.99%,SLC7A11;SLC1A3;SLC1A2;SLC1A1;SLC17A6
prerank,potassium:proton antiporter activity (GO:0015386),0.8442795151808482,1.7514981308954483,0.006734006734006734,0.6430678765555932,0.935,2/10,0.16%,SLC9A2;SLC9A4
prerank,retinoic acid binding (GO:0001972),-0.7081659390071893,-1.7501202215679765,0.0,0.12638801428693772,0.668,2/12,5.05%,NR2F2;CYP26B1
prerank,androgen receptor binding (GO:0050681),0.7253993604538589,1.7413033125051856,0.013138686131386862,0.6056686639715573,0.951,14/25,20.24%,PRKCB;DAXX;DDX5;EP300;TGFB1I1;KDM3A;KDM4C;SMARCA4;FOXP1;KDM1A;PRPF6;PARK7;ZBTB7A;PRMT2
prerank,C-C chemokine binding (GO:0019957),0.725182534822425,1.736816196330749,0.008902077151335312,0.5520520937183373,0.952,7/22,5.94%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6057116715200224,-1.7210759443842885,0.00847457627118644,0.1512548699744863,0.763,13/19,22.74%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GABRA1;GABRE;GRIK5;CHRNB1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7354773734385739,1.7191813143118289,0.015220700152207,0.571358471895937,0.972,6/18,6.89%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;S100A11;ANXA2
prerank,death domain binding (GO:0070513),0.8089028906265214,1.7157332237143428,0.018272425249169437,0.5315983650661831,0.976,1/11,0.02%,DAPL1
prerank,sodium:proton antiporter activity (GO:0015385),0.8094149650899418,1.707400949818849,0.01174496644295302,0.5189253575517857,0.979,2/11,0.16%,SLC9A2;SLC9A4
prerank,disordered domain specific binding (GO:0097718),0.7116204572500833,1.7057669807670792,0.015647226173541962,0.48213542417517263,0.98,2/23,1.24%,FN1;NCOA3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6805346250439375,-1.697956020436903,0.007389162561576354,0.17062042723115856,0.834,9/12,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,serine-type peptidase activity (GO:0008236),0.5720705162211972,1.69144963919758,0.0022346368715083797,0.4988937847493331,0.986,14/96,10.78%,DPP4;KLK11;KLK10;PIK3IP1;MMP9;HPN;PRSS12;PRSS36;GZMM;NAALAD2;PREP;KLK1;HP;HPR
prerank,ligand-gated channel activity (GO:0022834),-0.5123994824866,-1.689255101270434,0.0035714285714285713,0.17080307641155587,0.865,16/29,25.51%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK1;GRIK4;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,metal ion:proton antiporter activity (GO:0051139),0.7748354511778559,1.6864493008659474,0.01765650080256822,0.48134346866217315,0.988,2/13,0.16%,SLC9A2;SLC9A4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.8172803472433504,1.6862208414778304,0.011254019292604502,0.45018061023721967,0.988,3/10,2.15%,CXADR;DSG2;CD200
prerank,ligand-gated ion channel activity (GO:0015276),-0.5086612889642833,-1.6838599098960925,0.0,0.16608960929701672,0.876,16/30,25.51%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK1;GRIK4;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.7117028016200445,-1.6834677894307393,0.012531328320802004,0.155763221042839,0.877,4/10,8.59%,SLC24A3;SLC8A1;SLC8A3;SLC24A2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7845239286865016,1.6731395516482304,0.01652892561983471,0.4690829335001025,0.993,2/12,0.16%,SLC9A2;SLC9A4
prerank,glutamate receptor activity (GO:0008066),-0.5716711929816419,-1.6676219763229831,0.011299435028248588,0.1672707717263719,0.913,13/19,20.40%,GRIK2;GRID2;GRM3;GRM7;GRIA2;GRM8;GRM5;GRIK3;GRIK1;GRIK4;GRM1;GRIA4;GRIK5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5271501985516265,-1.6662864160429072,0.010526315789473684,0.15946654829042442,0.915,13/28,22.74%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GABRA1;GABRE;GRIK5;CHRNB1
prerank,5'-nucleotidase activity (GO:0008253),0.7726079607167734,1.6654035588766436,0.011235955056179775,0.46987506284003633,0.995,4/13,6.84%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,cell adhesion mediator activity (GO:0098631),-0.5359383057641554,-1.6486270207828597,0.0220125786163522,0.1759911828928418,0.941,11/24,10.61%,CD47;ESAM;PALLD;EMB;LRRC4C;NEXN;DSCAML1;CNTN6;BSG;NTNG1;ROBO4
prerank,sterol transfer activity (GO:0120015),-0.5813101300499594,-1.6485386028906133,0.02373887240356083,0.16694272418526354,0.942,5/17,10.44%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,nucleotidase activity (GO:0008252),0.7379360073026349,1.64838958043806,0.015408320493066256,0.5110674109013185,0.999,4/15,6.84%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,cytokine activity (GO:0005125),0.5409054706325984,1.6423236634088507,0.004324324324324324,0.5079464550305035,1.0,19/131,7.95%,WNT16;TNFRSF11B;CRLF1;WNT1;CCL5;WNT10A;IL15;GDF15;WNT11;IL16;WNT6;BMP5;CLCF1;TIMP1;EPO;BMP4;TGFB2;SLURP1;WNT5B
prerank,cholesterol transfer activity (GO:0120020),-0.5906720952120055,-1.6419018240493366,0.023323615160349854,0.1680085439514768,0.949,5/16,10.44%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,GABA-A receptor activity (GO:0004890),-0.5898651149822993,-1.6330891861899697,0.02586206896551724,0.17251028711812683,0.955,9/18,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,serine-type endopeptidase activity (GO:0004252),0.5577054296948487,1.6170023530608018,0.006888633754305396,0.5830802015037655,1.0,10/80,10.78%,DPP4;PIK3IP1;MMP9;HPN;PRSS12;PRSS36;GZMM;KLK1;HP;HPR
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4239595456506229,-1.606542026822742,0.0,0.2038009043142467,0.975,28/60,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;ACVRL1;TIE1;PDGFRA;KDR;BMPR1B;ACVR1B;EPHB2;EPHB4;ROR2;NTRK2;ACVR2A;ERBB4;FGFR2;RYK;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7807311568172876,1.6035495520356358,0.03529411764705882,0.6116260606663594,1.0,3/10,6.10%,DPP4;DPP7;NAALAD2
prerank,frizzled binding (GO:0005109),0.6200657999315087,1.6018532824506821,0.03773584905660377,0.5912264901659761,1.0,8/34,7.95%,WNT16;WNT1;WNT10A;WNT11;RNF43;WNT6;DVL3;WNT5B
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.6325689551789682,-1.5930363306967146,0.02717391304347826,0.21582326321209908,0.984,6/12,9.34%,IGF1;PIK3R1;INSR;GNAS;IGF2;ARRB1
prerank,potassium ion antiporter activity (GO:0022821),0.6968669487103485,1.5837806252221478,0.03827751196172249,0.6450392856067717,1.0,2/15,0.16%,SLC9A2;SLC9A4
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.6239873890957641,1.5597388992728605,0.0456490727532097,0.7309394778039258,1.0,2/27,0.16%,SLC9A2;SLC9A4
prerank,protein kinase C binding (GO:0005080),0.5920430656041143,1.5586963731109005,0.03238341968911917,0.7065472480035412,1.0,10/43,10.16%,PRKCB;PDLIM5;GRK5;HDAC5;CAVIN2;HSPB1;ADCY6;PARD6B;DACT2;NELL2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6155090886140889,-1.5525896612226333,0.036939313984168866,0.27535016263398204,0.997,5/13,3.60%,PDGFRB;PDGFD;PTPRJ;IL1R1;PDGFRA
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5853260383592959,1.552095438611988,0.044386422976501305,0.7104959327358651,1.0,21/37,21.36%,QARS1;EPRS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;HARS2;TARS1;SARS2;SARS1;YARS1;TARS3;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,receptor antagonist activity (GO:0048019),0.6717068834733071,1.5434722039269824,0.051643192488262914,0.7246695016529147,1.0,4/17,6.76%,CCL5;ADH7;IGSF1;PXDN
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6591488061859658,-1.5414973026309426,0.044009779951100246,0.2855432915371556,0.997,6/10,19.24%,GABRG3;GABRG2;GABRG1;GABRA3;GABRA1;GABRE
prerank,ankyrin binding (GO:0030506),0.6519243049902604,1.523750437037289,0.0734632683658171,0.7947096269476913,1.0,1/19,0.06%,CDH1
prerank,exopeptidase activity (GO:0008238),0.5536285817582008,1.5197031304419906,0.04050632911392405,0.788704541732549,1.0,6/50,7.07%,DPP4;CPB1;DPP7;NAALAD2;CTSZ;CPE
prerank,glycine binding (GO:0016594),-0.6214468460473636,-1.5194659017519434,0.05026455026455026,0.3172616263501539,0.998,10/11,35.08%,GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;GRIN3A;GRIN1;GLDC;GNMT
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5593225884208004,-1.5012907470243317,0.0641399416909621,0.3471957975819378,1.0,5/15,9.99%,SLC1A3;SLC1A5;SLC1A2;SLC1A1;SLC17A6
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6778289869685866,1.4965458547190713,0.06309148264984227,0.88083419797481,1.0,4/15,5.94%,CCR4;ACKR4;ACKR2;CCRL2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.539770192766726,-1.4961808923292552,0.05763688760806916,0.34682563271803735,1.0,8/17,11.93%,GRIK2;GRIN2A;GRIA3;GRIA2;GRIN2B;GRIK3;GRIK1;GRIK4
prerank,G protein-coupled receptor binding (GO:0001664),0.4956066455379241,1.4950387885669245,0.01737242128121607,0.8597228068918318,1.0,21/132,11.36%,WNT16;ITGB4;AGTR1;WNT1;CCL5;WNT10A;PENK;WNT11;ARHGEF12;RNF43;HOMER2;HOMER3;WNT6;CCRL2;DVL3;WNT5B;USP20;GRK2;GNAO1;GNAQ;GNA13
prerank,chemorepellent activity (GO:0045499),0.6152879728437602,1.4944383657529312,0.06,0.8362075048172882,1.0,3/25,2.81%,DPP4;SEMA3D;SEMA3B
prerank,Wnt-activated receptor activity (GO:0042813),-0.5572487807894613,-1.4931541301918951,0.05181347150259067,0.3416034535741404,1.0,7/15,11.00%,ROR1;FZD6;FZD4;LRP5;TSPAN12;RYK;FZD1
prerank,NAD binding (GO:0051287),-0.4688094421815494,-1.4918450190517867,0.06333333333333334,0.3325911111335009,1.0,11/26,28.69%,ALDH1A1;ZC3HAV1;ME1;HPGD;SIRT2;ALDH2;SORD;CRYZ;BDH2;NNT;SIRT6
prerank,ATP hydrolysis activity (GO:0140603),0.558714102152971,1.4847964062773336,0.0636604774535809,0.8620473368827166,1.0,14/41,20.12%,CFTR;CLU;ABCD1;SHOC1;TOR1A;VPS4B;CHD3;DHX9;HSP90AA1;MYO1E;KIF20B;ABCB6;MYO18A;ABCA4
prerank,receptor ligand activity (GO:0048018),0.4684966191439785,1.4800738829058373,0.004081632653061225,0.8600261404996316,1.0,31/245,8.78%,DPP4;WNT16;SEMA3D;TNFRSF11B;CRLF1;WNT1;CCL5;EDA;WNT10A;NBL1;IL15;GDF15;WNT11;SEMA3B;IL16;NGF;TNFSF13;GDNF;WNT6;BMP5;CLCF1;TIMP1;EPO;BMP4;OSGIN2;TGFB2;SLURP1;WNT5B;FGF22;LGALS3;VEGFB
prerank,enoyl-CoA hydratase activity (GO:0004300),0.7308197951123063,1.478546983845579,0.0726950354609929,0.8435106348726127,1.0,6/10,17.91%,ECHDC1;EHHADH;HADHA;AUH;HADHB;ECHS1
prerank,protein phosphatase 2A binding (GO:0051721),-0.48475718242125865,-1.4755833499573547,0.06060606060606061,0.3583324409007876,1.0,13/23,24.42%,CTTNBP2NL;MFHAS1;FOXO1;DAB2IP;TP53;PPME1;BOD1L1;MASTL;STRN;BOD1;SPHK1;ADCY8;GRIN3A
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6020971639191328,-1.469835305726549,0.0641025641025641,0.35797853181060235,1.0,3/10,4.94%,GNAS;SHANK3;SHISA6
prerank,carboxypeptidase activity (GO:0004180),0.584368387894871,1.4691234166279186,0.06442953020134229,0.8691455650152861,1.0,9/35,7.95%,CPB1;CPA4;CPA3;MINDY2;AGTPBP1;NAALAD2;CTSZ;CPE;AGBL1
prerank,growth factor receptor binding (GO:0070851),-0.35505917444472523,-1.4675039122216047,0.0,0.3520954343259296,1.0,19/95,12.85%,PDGFRB;PDGFD;HIP1;PTPRJ;IL1R1;TGFA;VEGFC;GLMN;PDGFRA;KL;FGF2;IL6R;JAK2;ERBB4;PLSCR1;LINGO1;GRB2;IL6ST;CNOT9
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.6960805831832483,1.4626086893499695,0.07704654895666131,0.8794673958502368,1.0,1/11,0.43%,NUDT4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.54010869834652,-1.4607300717917058,0.07605633802816901,0.35589653260537474,1.0,6/15,16.26%,HS6ST2;HS3ST3A1;NDST3;HS6ST3;HS3ST3B1;HS3ST1
prerank,protease binding (GO:0002020),0.5006805298528424,1.4600366639957245,0.02927927927927928,0.8684473418646524,1.0,14/99,10.93%,FN1;DPP4;LDLR;TIMP4;SERPINC1;TIMP1;TIMP2;LCOR;ANXA2;DVL3;ADAMTSL4;POLG;CARD16;ATP9A
prerank,potassium channel activity (GO:0005267),-0.3527538435105482,-1.4569369819964046,0.008547008547008548,0.35357824746801236,1.0,28/89,23.54%,KCNK2;KCNT2;GRIK2;KCND2;KCNK5;KCNN2;ABCC9;PKD2;KCNQ4;GRIK3;HCN2;GRIK1;GRIK4;CCDC51;KCNC1;TMEM38B;KCNMB4;KCNMA1;KCNK13;KCNH5;KCNQ3;HCN1;KCNK3;GRIK5;KCNK12;KCND1;KCNC3;KCNB2
prerank,chemokine binding (GO:0019956),0.5718089761694078,1.4537537712783979,0.07832167832167833,0.8768320494259941,1.0,7/30,5.94%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5231591383990253,1.4527210604135954,0.06435006435006435,0.8598261004635561,1.0,13/48,13.39%,TRPM3;ATP6V1B1;NALCN;TRPM8;CALHM5;TMEM165;TRPM6;AQP1;TRPM4;PKD2L1;SLC41A1;SLC12A4;TRPM2
prerank,pre-mRNA binding (GO:0036002),0.5738029099664634,1.448938190578267,0.08288043478260869,0.857187046378938,1.0,4/28,5.55%,CELF2;DDX5;CELF1;TARBP2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6840400626950727,1.4459699847942469,0.10031847133757962,0.8504892995722381,1.0,2/12,2.17%,B3GALT1;B4GAT1
prerank,MAP kinase kinase activity (GO:0004708),-0.5355095681823524,-1.4387512626964452,0.07323943661971831,0.38276527586764714,1.0,8/15,21.53%,PAK3;MAPK10;MAP2K6;LRRK2;MAP2K4;MAP2K1;MAP3K9;MAPK14
prerank,GABA receptor activity (GO:0016917),-0.5052523058637508,-1.4376244052551863,0.059006211180124224,0.3748955526712034,1.0,10/21,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GPR156;GABRB2;GABRA1;GABRE;GABRB3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5017830883134595,-1.436579945186287,0.0660377358490566,0.36727934908580195,1.0,6/18,8.35%,LTBP1;ENG;ACVRL1;BMPR1B;ACVR1B;ACVR2A
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6106278467493905,-1.436353897774561,0.0825,0.3584620628997792,1.0,3/10,5.48%,MECOM;SETD5;PRDM16
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.536984206932088,1.43413325120132,0.08196721311475409,0.8903306269697027,1.0,12/46,12.37%,B3GALT1;OGT;HEXA;B4GAT1;MGAT3;GCNT2;LARGE1;MGAT1;EXT1;HEXB;MGAT4C;PIGA
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.6593428801482755,1.4305990050382449,0.09666666666666666,0.8875844098358144,1.0,1/12,1.14%,OPN1SW
prerank,estrogen receptor binding (GO:0030331),-0.4396093482840246,-1.429536627200905,0.04609929078014184,0.3626786496929517,1.0,8/32,12.06%,LEF1;TACC1;ESR1;NCOA1;NSD1;RERG;PADI2;CCDC62
prerank,chloride transmembrane transporter activity (GO:0015108),0.6293627611062245,1.426757026590009,0.10124610591900311,0.8863723704577557,1.0,1/16,0.12%,CFTR
prerank,R-SMAD binding (GO:0070412),0.6077276890252511,1.4247769579327119,0.09785932721712538,0.8764927811080906,1.0,7/18,11.45%,SMAD6;DDX5;TRIM33;FOS;PPM1A;JUN;LDLRAD4
prerank,ferrous iron binding (GO:0008198),0.5992959891487403,1.4208135813147058,0.1133428981348637,0.8761386990196162,1.0,4/21,11.33%,EGLN3;EGLN2;HEPH;CDO1
prerank,neuropeptide receptor activity (GO:0008188),0.5624321132066323,1.4106297735262612,0.09237536656891496,0.907944490017198,1.0,2/29,1.37%,SORCS2;GAL
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3701584421094062,-1.4078980826689662,0.011111111111111112,0.39850869121226035,1.0,25/60,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;TIE1;PDGFRA;KDR;IGF2R;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,insulin-like growth factor I binding (GO:0031994),0.6518627697486346,1.4073131531129202,0.10126582278481013,0.9053014018152312,1.0,2/13,0.78%,ITGB4;IGFBP6
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5109515794999404,1.4060064383444484,0.08220858895705521,0.8936690781872784,1.0,7/55,7.34%,SLC7A14;SLC36A3;SLC16A5;SLC16A11;SLC16A2;SLC36A4;SLC3A1
prerank,phosphatase activity (GO:0016791),0.4894270252791427,1.404613381481503,0.07629107981220658,0.8823371751801653,1.0,4/73,5.44%,PLPPR2;ATP1A2;DUSP10;DUSP12
prerank,nucleotide diphosphatase activity (GO:0004551),0.6483742796527892,1.4039916773123509,0.10785824345146379,0.8683478509279479,1.0,2/14,2.11%,NUDT4;FHIT
prerank,chloride channel inhibitor activity (GO:0019869),0.6774469359650607,1.3971149807472971,0.13132911392405064,0.8830248214135277,1.0,1/10,0.12%,CFTR
prerank,neuropeptide binding (GO:0042923),-0.4933712420317767,-1.3957971275547159,0.09798270893371758,0.4161810676724809,1.0,12/18,44.30%,GPR37;SORL1;OPRM1;OPRK1;NMUR2;GPR149;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,O-acyltransferase activity (GO:0008374),0.5474718375667078,1.3938518569843912,0.107095046854083,0.8820440643406062,1.0,10/30,12.85%,MBOAT2;SOAT1;DGAT1;MOGAT3;MOGAT1;SOAT2;GPAM;MBOAT7;LPCAT2;LPCAT3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5639984495617129,-1.3914523778975956,0.09863013698630137,0.4156846554600721,1.0,7/11,27.56%,CFLAR;CASP9;CASP4;CASP7;CASP2;PYCARD;CASP1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4893505662363686,1.3914392810384986,0.09557109557109557,0.8777411657514481,1.0,12/70,12.11%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;GCNT2;LARGE1;CHPF;EXT1;HEXB;CHPF2;MGAT4C
prerank,NF-kappaB binding (GO:0051059),0.570207739594357,1.390217686246343,0.1070931849791377,0.8675458936805706,1.0,9/24,14.36%,EP300;ANXA4;MTDH;NFKBIA;COMMD7;FOXP3;HDAC3;COMMD6;GSK3B
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6498185140390449,1.3887454628979317,0.12355848434925865,0.858161251957399,1.0,5/11,19.70%,MAP3K5;MAP3K4;MAP3K13;MAP3K6;MAP3K1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5811266181026727,-1.38765487016237,0.10498687664041995,0.41474825431994844,1.0,7/10,32.96%,ADARB2;GDA;APOBEC1;CDA;ADA;DCTD;LACC1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.618104114939081,1.3855288249714501,0.12264150943396226,0.8584985254242402,1.0,1/15,0.12%,CFTR
prerank,potassium ion leak channel activity (GO:0022841),-0.513182295524541,-1.3852193534408141,0.10755813953488372,0.41100414379407646,1.0,8/15,32.17%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNK6;KCNK4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.48263056951771666,-1.3847622805681967,0.09294871794871795,0.4029541553309127,1.0,6/18,5.66%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2;ALDH6A1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4396124851061718,-1.3804605726720223,0.07508532423208192,0.4028896717462118,1.0,10/26,10.11%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;SLC6A6;SLC16A6;SLC16A1;SLC16A4;SLC6A1;SLC16A7
prerank,proton transmembrane transporter activity (GO:0015078),0.5208194095277321,1.3794548455518871,0.09973045822102426,0.8714123114507142,1.0,18/39,24.96%,ATP6V1B1;COX5A;CTNS;COX8A;UQCRC1;COX7A2L;CLCN4;COX5B;UQCR11;SLC9A1;SLC11A2;UQCRH;ATP6V1B2;COX4I1;COX10;SLC4A11;UQCRFS1;CYB5A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.630716093207519,1.3780808710634125,0.11532385466034756,0.8631771361043823,1.0,5/14,11.05%,MINDY2;MINDY3;OTUD7B;DESI2;MINDY4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5153777496714046,1.3775839904940719,0.09987515605493133,0.8512078146302764,1.0,6/47,7.34%,SLC7A14;SLC36A3;SLC66A1;SLC16A2;SLC36A4;SLC3A1
prerank,chloride channel regulator activity (GO:0017081),0.6335251392730201,1.371626810923753,0.12322274881516587,0.8627975922826974,1.0,2/14,3.69%,CFTR;SGK3
prerank,kinase activator activity (GO:0019209),0.5393413067767037,1.3682804767894383,0.12347354138398914,0.8640589253770653,1.0,5/30,4.46%,FGF13;DAXX;WNT11;GPRC5A;EPO
prerank,sulfotransferase activity (GO:0008146),0.5350474651954198,1.3664787236840736,0.13728129205921938,0.8582995175605129,1.0,5/33,5.34%,UST;SULT1A1;CHST12;SULT2B1;CHST11
prerank,glucuronosyltransferase activity (GO:0015020),0.5833118601062656,1.362119936634671,0.12794117647058822,0.863455911718947,1.0,4/19,9.56%,B4GAT1;LARGE1;CHPF;EXT1
prerank,Hsp70 protein binding (GO:0030544),-0.41492646846677766,-1.3598508245999532,0.0636042402826855,0.43827486234464974,1.0,7/31,8.26%,PACRG;SACS;TSC1;DNAJC18;GPR37;DNAJA1;DNAJB12
prerank,sialyltransferase activity (GO:0008373),-0.47042169704351017,-1.3593452416489609,0.1,0.4306388419359724,1.0,7/20,8.01%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST3GAL3;ST6GALNAC5;ST8SIA6
prerank,insulin-like growth factor binding (GO:0005520),0.6178722560188787,1.358909792088673,0.13198757763975155,0.8649508155748803,1.0,2/15,0.78%,ITGB4;IGFBP6
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.522346080355449,1.3551833034140917,0.1243455497382199,0.8680460482538283,1.0,7/32,15.76%,EGLN3;KDM4B;EGLN2;RIOX2;KDM4C;TET1;JMJD4
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6538550580099282,1.351256397869395,0.15097402597402598,0.8729922391883186,1.0,7/10,25.19%,GFUS;DSE;GALE;FUOM;GNE;RPE;GLCE
prerank,sterol binding (GO:0032934),0.4811179497291686,1.349940501624115,0.10948905109489052,0.866182455668898,1.0,16/56,11.53%,RORC;SYP;OSBPL9;SOAT1;CAV1;STARD3;CD81;SULT2B1;ERLIN2;INSIG1;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4
prerank,protein tyrosine kinase activity (GO:0004713),-0.31949789077235613,-1.3452636268542268,0.02654867256637168,0.452330695253976,1.0,32/108,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;LYN;PTK2;AXL;TIE1;PDGFRA;KDR;BAZ1B;EPHB2;EPHB4;ROR2;BMX;PKDCC;NTRK2;JAK2;ERBB4;FGFR2;RYK;KIT;ABL2;IGF1R;TYK2;FGFR4;FLT4;RET;EPHA5
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3308134091042162,-1.3405449922763415,0.023076923076923078,0.4547550177786615,1.0,24/80,25.53%,KCNK2;KCNT2;KCND2;KCNN2;PKD2;KCNQ4;KCNJ2;HCN2;KCNJ12;KCNJ6;KCNC1;KCNJ10;KCNMA1;KCNH5;KCNQ3;HCN1;KCNJ8;KCNJ15;KCNIP2;KCND1;KCNC3;KCNB2;KCNK1;KCNJ3
prerank,phospholipase inhibitor activity (GO:0004859),0.64444388888406,1.3405183750755665,0.1546218487394958,0.8938506369436914,1.0,4/10,15.14%,ANXA4;ANXA5;ANXA2;SNCB
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5495243623298278,-1.3389220255618535,0.13783783783783785,0.44961052710305865,1.0,6/10,27.56%,CFLAR;CASP9;CASP4;CASP7;CASP2;CASP1
prerank,actin binding (GO:0003779),0.43415080136592893,1.3373904871694409,0.07006369426751592,0.895091861144389,1.0,28/170,7.83%,SORBS1;UTRN;PHACTR1;PAWR;PDLIM5;CALD1;COBL;ABLIM1;PHACTR2;PARVA;DAG1;GSN;MICAL2;SSH3;EPS8L2;CXCR4;CORO7;MLPH;LMOD3;CAPZB;TWF1;AVIL;ADD1;DMTN;FLNB;ANG;MICAL1;MSRB2
prerank,GDP binding (GO:0019003),0.4763912238405471,1.336160417508093,0.12274368231046931,0.8875831561748938,1.0,24/63,23.45%,RAB17;MRAS;RAP1B;RAP1A;RAB9B;ARL3;NRAS;KRAS;RHEB;RAB3B;RAB7A;RAB35;RAB5C;HRAS;RAP2C;DIRAS2;RAB8B;RAB27A;RAB9A;RAB10;MIEF1;GNAI3;ARL8B;RAB31
prerank,general transcription initiation factor binding (GO:0140296),-0.4247603613363663,-1.3320180661319756,0.1111111111111111,0.4567563685886977,1.0,12/25,27.99%,AR;ESR1;TAF1B;RUVBL1;TAF12;THAP7;HHEX;AHR;YEATS2;GTF2A2;DRAP1;TAF1
prerank,lipase activator activity (GO:0060229),0.6391304508658922,1.3307332334154793,0.16838487972508592,0.8984515892051467,1.0,1/10,1.51%,CCL5
prerank,low-density lipoprotein particle binding (GO:0030169),0.5828804817040193,1.327746106430267,0.15950920245398773,0.8992448794721702,1.0,2/16,1.18%,CDH13;LDLR
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6342535375999085,1.3253181642147174,0.17041800643086816,0.8865808212777786,1.0,2/10,5.44%,DUSP10;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6342535375999085,1.3253181642147174,0.17041800643086816,0.8865808212777786,1.0,2/10,5.44%,DUSP10;DUSP1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5166887547805386,-1.3171222717484607,0.14039408866995073,0.4825953745264788,1.0,4/12,5.07%,LTBP1;ENG;ACVRL1;BMPR1B
prerank,metallocarboxypeptidase activity (GO:0004181),0.5468579391472064,1.3163029362805576,0.15263908701854492,0.9138543371442253,1.0,6/26,7.95%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,deubiquitinase activity (GO:0101005),0.4521690840973336,1.315356909151829,0.11136363636363636,0.9059825588941502,1.0,27/88,18.28%,USP53;MINDY2;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP10;USP32;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;MINDY4;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP21;USP16
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6458543709224399,1.314811565478118,0.17470881863560733,0.896839569516879,1.0,1/10,0.66%,B3GALT1
prerank,myosin II binding (GO:0045159),0.6234569327003369,1.3094179946379256,0.1797945205479452,0.9075597414806588,1.0,5/10,21.85%,GSN;LLGL2;MYL4;SHROOM4;LLGL1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.6287233585189759,1.309035438180433,0.18166939443535188,0.8978998104820192,1.0,4/10,19.31%,DAXX;PML;FAN1;IDE
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5109003194872862,1.3082144617924005,0.14555256064690028,0.8901948987976998,1.0,17/35,20.86%,FOS;SMARCB1;PIH1D1;TAF1C;ZBTB17;UBTF;SMARCA4;DR1;MMP12;MYC;FOXP1;TBPL1;H3-3A;PARK7;TBP;SNAPC3;KLF10
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6077805945632749,1.3067408144031978,0.19381107491856678,0.8856184580513987,1.0,4/11,12.82%,CNGA2;CNGB3;AQP1;CNGB1
prerank,cadherin binding (GO:0045296),0.40919696689239776,1.3032482029261325,0.04757085020242915,0.8887868497531094,1.0,62/315,12.98%,CDH1;PHLDB2;CDH13;BAIAP2L1;PLCB3;PDLIM5;CALD1;TJP2;FMNL2;TJP1;AHNAK;STXBP6;PARVA;TMOD3;NIBAN2;PKP4;NDRG1;MPRIP;ARHGAP18;EPS8L2;GPRC5A;SH3GLB2;CTNNA1;EHD1;PPP1R13L;TRIM25;SPTBN2;PFKP;S100A11;CAPZB;PAICS;TWF1;PKM;MRE11;ADD1;TES;HCFC1;ANK3;CC2D1A;ANXA2;FLNB;CLIC1;IQGAP1;CHMP4B;GOLGA3;PI4KA;YWHAB;BAG3;EZR;ABI1;PLEC;SPTAN1;ARFIP2;CDH4;YWHAZ;FASN;ARGLU1;RPS26;EIF4G2;OLA1;ESYT2;EEF1D
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4282588951495132,-1.299437974111441,0.13553113553113552,0.5168753575054739,1.0,7/25,7.18%,POR;FMO1;NOS3;MICAL3;FMO2;CYP26B1;FMO5
prerank,nuclear localization sequence binding (GO:0008139),0.5537702547801003,1.2971626817070039,0.1661676646706587,0.9040758325311986,1.0,9/18,17.56%,KPNA7;NFKBIA;TNPO2;KPNA4;TNPO1;BRAP;RANBP6;IPO4;KPNA1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5339477445095125,1.2954511428205897,0.1685878962536023,0.9005020736521073,1.0,4/23,1.59%,PLCB3;CHRM1;CCL5;PLCD3
prerank,SUMO transferase activity (GO:0019789),0.5849693919875192,1.2940314933577377,0.18882175226586104,0.8960403959751059,1.0,7/16,15.23%,HDAC4;MUL1;NSMCE2;PIAS1;PIAS3;CBX4;MDM2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5303273304661638,-1.2925065064806536,0.17590361445783131,0.525544594144313,1.0,6/10,31.66%,SETD5;NSD1;NSD3;PRDM9;NSD2;SETD3
prerank,E-box binding (GO:0070888),-0.3894896749260021,-1.291675445842456,0.1070110701107011,0.5183597472697173,1.0,5/34,9.23%,TCF4;ZEB1;MITF;ATOH8;PPARG
prerank,GTPase activator activity (GO:0005096),-0.2654021929668896,-1.2904030253895211,0.0,0.512668357135921,1.0,75/313,12.13%,PLCB1;DOCK4;FARP1;ALDH1A1;PREX2;DENND4A;ERRFI1;TBC1D4;ARHGAP28;ARHGAP24;ADGRB3;ARHGAP32;RAPGEF2;DENND5B;ARHGAP20;FGD5;RASGRP3;ASAP1;TBC1D12;VAV3;CHN2;DENND1A;DOCK10;PLCE1;RGS5;RASGRF2;RP2;ARHGEF28;CHN1;RASGRP2;RGS3;SH3BP5;RIC1;EIF2B3;RABGAP1L;ARHGAP22;SYDE2;TBC1D30;RALGPS1;RABIF;FNIP1;DOCK8;LRRK2;MTSS2;RALGAPA2;SPATA13;ARHGEF15;ELMOD2;RAB3IL1;RGL1;RIC8B;TIAM1;GARNL3;SGSM3;TBC1D14;ARRB1;FGD3;NF1;NPRL3;WDR41;ELMOD1;NCKAP1L;ARAP3;ALS2;DENND2C;TBC1D5;PGAM5;STARD8;ARHGEF2;RCC1;STXBP5L;LAMTOR1;ACAP2;TBC1D7;DENND4C
prerank,double-stranded RNA binding (GO:0003725),0.45737228964057675,1.284904141172097,0.14614499424626007,0.9226630960557766,1.0,18/70,15.49%,MBNL1;STRBP;VIM;DGCR8;MTDH;TARBP2;MSN;SIDT2;EIF4B;ILF2;FXR1;DUS2;ZFR2;APTX;EIF4A1;TLR3;DHX9;OAS2
prerank,leucine zipper domain binding (GO:0043522),0.6182052125507855,1.2846119851297133,0.17728055077452667,0.9135678987652761,1.0,2/10,3.76%,PAWR;DAPK3
prerank,deoxyribonuclease activity (GO:0004536),0.5895245257667499,1.2834209724851366,0.21350078492935637,0.9079734495844646,1.0,8/14,23.60%,MRE11;DNASE1L2;ERCC5;MBD4;DNASE1L1;ERCC4;MAP1S;APEX1
prerank,hexosyltransferase activity (GO:0016758),0.43377159194903164,1.2767963803465694,0.13528748590755355,0.9256114172347165,1.0,19/101,13.79%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;TMTC1;A4GALT;GCNT2;LARGE1;CHPF;MTAP;EXT1;PIGZ;HEXB;ALG1;CHPF2;MGAT4C;ALG12;ALG5
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.5155620912262934,1.2762381018497866,0.19204389574759945,0.9177520701737226,1.0,3/26,6.69%,B3GALT1;B4GALNT2;CHPF
prerank,nuclear receptor coactivator activity (GO:0030374),0.46188691965593737,1.2761624299597132,0.15889029003783103,0.9081506767979657,1.0,14/52,16.82%,PRKCB;CNOT6;PPARGC1A;NCOA3;MED30;ENY2;CALCOCO1;DCAF6;MED12;MED24;ZMIZ2;ACTN4;SFR1;KDM1A
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5938239205865109,1.274874780038949,0.1967479674796748,0.9035701869919588,1.0,7/13,14.36%,SOX9;CSK;EZR;PKIA;GSK3A;PRKAR2A;GSK3B
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.429550649262754,-1.2738875222166648,0.13291139240506328,0.5425795127375865,1.0,11/21,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE9A;PDE4B;PDE2A
prerank,iron ion binding (GO:0005506),0.4710836453585944,1.2727764730908881,0.1731984829329962,0.9028800496032944,1.0,18/48,23.54%,EGLN3;ALOX5;EGLN2;FDX1;KDM3A;HEPH;CDO1;SCD5;ACO2;TET1;HAAO;ISCA2;TYW5;MELTF;PHF2;AOX1;FTO;FTL
prerank,TBP-class protein binding (GO:0017025),-0.42256879478963505,-1.2726807938859548,0.14860681114551083,0.536402808353862,1.0,10/21,27.99%,ESR1;TAF1B;RUVBL1;TAF12;HHEX;AHR;YEATS2;GTF2A2;DRAP1;TAF1
prerank,protein kinase C activity (GO:0004697),0.5732436884849974,1.268940597204133,0.20294599018003273,0.9090097883844978,1.0,1/14,0.09%,PRKCB
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5693238935900856,1.2670071495481547,0.17584097859327216,0.9074282078938405,1.0,8/17,23.43%,DHCR7;SRD5A3;PECR;BLVRA;TM7SF2;DECR2;MECR;DECR1
prerank,phosphatase binding (GO:0019902),0.4230615795829524,1.2666126905923998,0.13901345291479822,0.8995669009151325,1.0,24/105,13.37%,NFATC2;MAP3K5;ANK1;MAGI2;GTF2F1;IKBKE;PPP6R3;CHCHD3;SH3RF2;AP3B1;TSC2;ROS1;PXN;BAD;LGALS3;IQGAP1;CRY2;MTMR3;JAK1;MVP;EIF2AK3;ELL;ANAPC4;CARHSP1
prerank,phosphatidic acid binding (GO:0070300),-0.4419204950471304,-1.2619734401183642,0.17765042979942694,0.5538838534298074,1.0,6/19,10.44%,MARK1;RAPGEF2;PLTP;SMPD3;GSDMD;GRAMD1B
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4606784803573352,1.2609244504052437,0.18218085106382978,0.9129961166968499,1.0,7/42,6.89%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;CD200;S100A11;ANXA2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4155789093044863,-1.2595887260138932,0.1423948220064725,0.55094105183752,1.0,11/23,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE9A;PDE4B;PDE2A
prerank,lipoprotein particle binding (GO:0071813),0.5348320590352107,1.2594259485411246,0.21783625730994152,0.9098136232301923,1.0,2/20,1.18%,CDH13;LDLR
prerank,phospholipase C activity (GO:0004629),0.511771621705529,1.2587190872458967,0.19127988748241911,0.903577821462128,1.0,4/25,1.59%,PLCB3;CHRM1;CCL5;PLCD3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5054664132333927,-1.2578475618384717,0.18617021276595744,0.5460887440907894,1.0,5/12,20.98%,ENTPD1;CANT1;ENTPD3;ENTPD5;ENTPD6
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.48426348617929066,1.2555828895028835,0.18265440210249673,0.9069357723170366,1.0,9/34,8.45%,ARAP1;OGT;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;JPH2;IQGAP1
prerank,metallopeptidase activity (GO:0008237),0.41236215856506925,1.2548939368428238,0.13631406761177753,0.9010417903881175,1.0,20/113,13.27%,ADAM12;THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1;ADAM15;PSMD7;MMP12;COPS5;MPND;MYSM1;CHMP1A
prerank,metalloendopeptidase activity (GO:0004222),0.4281586428500092,1.2547423127049528,0.15813953488372093,0.892922112294007,1.0,12/76,9.04%,THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1
prerank,phospholipase activator activity (GO:0016004),0.5966870055027949,1.2541285651133518,0.2322357019064125,0.8866402957059346,1.0,1/10,1.51%,CCL5
prerank,FMN binding (GO:0010181),-0.5144958855016293,-1.2528917610271852,0.20221606648199447,0.5488929953199699,1.0,2/11,2.50%,POR;NOS3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4322884142889979,1.2525789866945691,0.16210045662100456,0.8839427850551795,1.0,25/83,18.28%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP10;USP32;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP21;USP16
prerank,5'-3' exonuclease activity (GO:0008409),0.5749656469257137,1.2499097361527325,0.2319327731092437,0.8856848674954688,1.0,6/14,19.74%,FEN1;MRE11;XRN2;FAN1;DCLRE1C;DXO
prerank,fibroblast growth factor binding (GO:0017134),0.5255644934399792,1.2495392755045462,0.2,0.8789550438321903,1.0,2/21,1.48%,FGFR1;GPC1
prerank,alkali metal ion binding (GO:0031420),0.5807186290990816,1.2491470686892912,0.22257551669316375,0.8723487031719077,1.0,2/13,4.08%,ATP1A2;HDAC4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5827790169935874,1.247690820282547,0.22706766917293233,0.8698972601032918,1.0,3/11,10.36%,ALDH3A1;DHRS13;AKR1B10
prerank,MAP kinase phosphatase activity (GO:0033549),0.5836767032672452,1.244865959616104,0.24881141045958796,0.8731253624318963,1.0,6/12,27.00%,DUSP10;DUSP1;DUSP3;DUSP16;DUSP29;DUSP8
prerank,acetylcholine receptor activity (GO:0015464),0.524783665780168,1.2440263157960072,0.21304347826086956,0.8684235458722156,1.0,1/22,0.76%,CHRM1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5075608947768628,-1.2437496689742287,0.1945945945945946,0.5612704942649578,1.0,5/11,14.97%,LEF1;MBD2;GATA2;HMGA2;THAP7
prerank,calcium channel regulator activity (GO:0005246),-0.36627625223563753,-1.239317918207018,0.17142857142857143,0.5643148054093984,1.0,9/37,12.48%,PRKG1;ITPR1;STIM1;NRXN1;SGK1;STIMATE;CACNG8;REM1;SLC30A1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5693225796140278,1.2376156400330969,0.2528180354267311,0.883821097261614,1.0,4/12,14.93%,DHRS4;CRYZL1;NQO2;DCXR
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5182872761152906,1.2367325325832692,0.23179791976225855,0.8792908490065074,1.0,9/22,23.33%,MINDY2;IKBKE;OTUD7B;TAB3;IKBKG;TAB2;PRPF8;RNF168;RNF169
prerank,alanine transmembrane transporter activity (GO:0022858),0.5883987535529448,1.2360138423514402,0.2310177705977383,0.8743645227236432,1.0,3/12,10.88%,SLC36A3;SLC36A4;SLC1A4
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5284672766806001,1.2356166684033811,0.22507552870090636,0.8681108192292156,1.0,5/20,11.95%,ABHD5;DGAT1;MOGAT3;MOGAT1;LPCAT2
prerank,nuclear export signal receptor activity (GO:0005049),-0.5106428632506177,-1.2348966929520881,0.21634615384615385,0.5672226766601745,1.0,5/11,15.61%,XPO1;EIF4ENIF1;RAN;RANBP17;NUP214
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5371691559574192,1.2319106661360912,0.23617339312406577,0.8739636732396079,1.0,4/17,6.77%,PITPNM2;ATP10A;PITPNC1;ATP8B2
prerank,ribosome binding (GO:0043022),0.4549747120358874,1.2310208027096292,0.20076238881829733,0.8698388182559005,1.0,23/46,24.56%,CPEB2;YTHDF1;ZC3H12A;EIF6;RPSA;MRPS27;NAA15;CPEB3;NAA10;PYM1;CCDC47;EEF2;TMEM147;YTHDF3;ETF1;GEMIN5;IGHMBP2;EFL1;GTPBP6;C1QBP;EIF2S1;EIF2A;MAIP1
prerank,N-acyltransferase activity (GO:0016410),-0.37239635113683106,-1.2298667681221176,0.1686746987951807,0.5716313073946726,1.0,9/32,12.82%,TGM2;SAT1;NMT2;CERS4;PLAAT3;NAT10;SMARCE1;CERS5;CERS6
prerank,protein kinase regulator activity (GO:0019887),0.41754489134691014,1.229846746232736,0.18303571428571427,0.8666927510866722,1.0,27/95,19.02%,FGF13;DAXX;PARVA;CDKN1A;WNT11;QARS1;GPRC5A;EPO;ITPRIP;CCND2;ELP4;YWHAB;GPRC5D;CCND1;SMCR8;CCNL2;PRKAR2A;DUS2;WNK1;DNAJC3;PPP1R1B;HEXIM1;CCNG1;PRKAG1;CAB39;SH3BP5L;TAOK3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.44939766898619604,-1.2266048395914722,0.19827586206896552,0.571694203577546,1.0,8/15,18.52%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1;ALDH7A1;ALDH2;ALDH3B1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.4463856890414051,1.2249234464461647,0.21012658227848102,0.8771025508784825,1.0,13/51,16.25%,SLCO2A1;ANKH;SLC35D3;MCU;SLC25A3;SLC16A2;SLC20A1;CLCN4;SLC22A8;SLC25A14;SLC35E2B;SLC35E2A;SLC4A4
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5606277741258401,1.223169935786547,0.2455573505654281,0.8761229858227771,1.0,8/12,23.99%,NAPSA;SPPL2B;HM13;BACE1;SPPL3;SPPL2A;DDI2;PSEN1
prerank,peptidase inhibitor activity (GO:0030414),0.4873355024553764,1.2219585128147548,0.2178988326848249,0.8733038966335386,1.0,6/33,7.22%,SLPI;SPINT2;TIMP1;TIMP2;PSMF1;GPC3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5733233582371594,1.2213881122255719,0.2476489028213166,0.8683268938570234,1.0,5/14,5.53%,COL4A3;NGF;TIMP4;TIMP1;TIMP2
prerank,vinculin binding (GO:0017166),0.5841033056457149,1.2198710621440487,0.2754098360655738,0.8666170522604133,1.0,4/11,6.77%,UTRN;DAG1;CTNNA1;PXN
prerank,bHLH transcription factor binding (GO:0043425),-0.4314012368595207,-1.2189802340986127,0.21515151515151515,0.5823094433261534,1.0,5/19,13.93%,FHL2;TCF12;LMO2;BHLHE40;SMAD3
prerank,mRNA 3'-UTR binding (GO:0003730),0.41800236758948106,1.2145731657094194,0.19460726846424384,0.8778104881857148,1.0,17/79,13.99%,CELF2;PABPC4L;DDX5;CPEB2;ZC3H12A;PABPC1L;CELF1;YBX3;UTP23;RBMS3;CPEB3;FXR1;DAZAP1;CARHSP1;RNPS1;BOLL;AUH
prerank,cholesterol binding (GO:0015485),0.44105933521046253,1.214129947535663,0.201765447667087,0.8724985706947017,1.0,15/47,15.04%,SYP;SOAT1;CAV1;STARD3;CD81;SULT2B1;ERLIN2;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4;VDAC1;OSBPL5
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5607988682891696,1.210812178332917,0.2698412698412698,0.8770742102445998,1.0,5/13,15.73%,FEN1;DNASE1L2;DNASE1L1;ENDOV;FAN1
prerank,endonuclease activity (GO:0004519),0.4417612351992676,1.2067029226997885,0.2230769230769231,0.8850535034984984,1.0,12/49,13.77%,ZC3H12A;FEN1;KHNYN;RNASEL;MRE11;ANG;TSNAX;YBEY;LACTB2;ERCC5;MBD4;REXO4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.28409416444893726,-1.2018386775366507,0.09259259259259259,0.6176361048362486,1.0,36/147,12.58%,DOCK4;FARP1;PREX2;DENND4A;RAPGEF2;DENND5B;FGD5;VAV3;DENND1A;DOCK10;PLCE1;RASGRF2;ARHGEF28;RASGRP2;SH3BP5;RIC1;EIF2B3;RALGPS1;RABIF;FNIP1;DOCK8;SPATA13;ARHGEF15;RAB3IL1;RGL1;RIC8B;TIAM1;FGD3;WDR41;ALS2;DENND2C;ARHGEF2;RCC1;LAMTOR1;DENND4C;RASGEF1A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.44581684261113397,-1.2013564288518361,0.23978201634877383,0.6101461103022793,1.0,8/15,24.38%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR
prerank,phospholipase A2 activity (GO:0004623),0.4903315406958862,1.2001743241402916,0.2514124293785311,0.9008907668473108,1.0,2/26,5.57%,PLB1;PLA2G12A
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5003761118258588,1.1973779212027265,0.26398852223816355,0.904409195151677,1.0,4/22,12.40%,CLU;APBB1;AP2A1;MESD
prerank,amyloid-beta binding (GO:0001540),0.4119983633796912,1.1962230095354263,0.21363636363636362,0.9014465884218894,1.0,12/79,9.68%,CLU;COL25A1;LDLR;EPHA4;CACNA1A;ITM2C;PFDN1;CRYAB;TGFB2;FZD5;TLR6;APBB1
prerank,exoribonuclease activity (GO:0004532),0.5638039811230591,1.1961268053825964,0.28253968253968254,0.894948414083556,1.0,3/12,8.90%,CNOT6;ZC3H12A;EXOSC3
prerank,solute:proton symporter activity (GO:0015295),0.5238028534646929,1.1931929798830228,0.2878787878787879,0.8985665360566067,1.0,3/16,5.97%,SLC36A3;SLC25A3;CTNS
prerank,GABA receptor binding (GO:0050811),0.5663121450656684,1.1929173888811517,0.2784184514003295,0.8927425696266836,1.0,2/11,10.21%,PLCL2;AKAP5
prerank,ligand-gated anion channel activity (GO:0099095),0.5191406176932784,1.1921786657907179,0.256797583081571,0.8886744262175991,1.0,1/17,0.12%,CFTR
prerank,cGMP binding (GO:0030553),0.5620391579509953,1.1914917308751292,0.2943089430894309,0.8846077025969342,1.0,4/11,12.82%,PDE5A;CNGA2;CNGB3;CNGB1
prerank,neuropeptide hormone activity (GO:0005184),0.5024961770525179,1.1913708634831524,0.26880222841225626,0.8786073008648065,1.0,2/22,2.38%,GAL;PENK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4266716499984377,-1.1889772399740008,0.24786324786324787,0.6248580081368502,1.0,3/16,0.50%,PTPRM;PTPRG;PTPRB
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4266716499984377,-1.1889772399740008,0.24786324786324787,0.6248580081368502,1.0,3/16,0.50%,PTPRM;PTPRG;PTPRB
prerank,nuclear import signal receptor activity (GO:0061608),0.5185016602760774,1.1885292708883717,0.27314814814814814,0.8820760417785817,1.0,8/15,20.57%,KPNA7;TNPO2;KPNA4;TNPO1;RANBP6;IPO4;KPNA1;HIKESHI
prerank,protein tyrosine kinase binding (GO:1990782),0.41249021053491797,1.1885132235004794,0.22470588235294117,0.8758016025894647,1.0,9/71,7.75%,PITPNM2;ANGPT1;PTPN14;TJP2;EPHA4;PRR7;PITPNM3;SHC1;FIZ1
prerank,kinase inhibitor activity (GO:0019210),0.4550104167840973,1.1870197370455757,0.23687752355316286,0.8743117942125246,1.0,12/33,19.02%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;SH3BP5L;TAOK3
prerank,nuclear receptor binding (GO:0016922),0.3951873590791117,1.1847810315412728,0.23196448390677027,0.8760612387789034,1.0,30/111,20.24%,PRKCB;DAXX;PPARGC1A;NCOA3;DDX5;EP300;LCOR;MED30;LATS1;TGFB1I1;TCF7L2;GAS2L1;BCAS3;KDM3A;KDM4C;SMARCA4;NCOR1;MED12;MED24;FOXP1;NCOR2;ACTN4;KDM1A;PRPF6;PARK7;ZBTB7A;YWHAH;TACC2;DCAF1;PRMT2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.37603409307629987,1.180134368044693,0.17604912998976457,0.885589393881201,1.0,63/248,19.44%,CFTR;RAB17;CLU;DYNC1I1;MRAS;RAP1B;ABCD1;EEF1A1;KIF2A;RAP1A;SHOC1;RHOQ;KIF1C;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;TOR1A;BMS1;RAB35;GNAO1;AGAP3;GNAQ;KLC1;GNA13;VPS4B;RHOA;RABL3;OPA1;CHD3;SEPTIN9;RHOU;RAB5C;RAB1B;HRAS;GNG5;DNM1L;ATL2;GNA11;GPN1;DHX9;ARHGDIB;HSP90AA1;RAP2C;RAB33B;ARL8A;EEF2;DIRAS2;RAP1GAP;RAB8B;MYO1E;HBS1L;KIF20B;RNF112;ABCB6;RAB27A;RAB9A;RHOT2;MYO18A
prerank,adenyl nucleotide binding (GO:0030554),0.5689487465808755,1.17997853364925,0.28311258278145696,0.8737653055077831,1.0,5/11,15.52%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5689487465808755,1.17997853364925,0.28311258278145696,0.8737653055077831,1.0,5/11,15.52%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.48812875702484787,-1.1783015150768443,0.2751196172248804,0.6433373802914818,1.0,3/10,9.87%,PRKAG2;PKIG;PRKAR2B
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.48349722627246106,1.1763749839268234,0.2708638360175695,0.8795651127018941,1.0,6/24,10.00%,IP6K1;PMVK;CMPK1;PPIP5K2;AK5;AK3
prerank,G protein-coupled receptor activity (GO:0004930),0.3717062409301882,1.1741515319113593,0.18061224489795918,0.881014642714881,1.0,21/239,11.56%,ADRA1B;AGTR1;GPR4;LPAR1;OPN1SW;LPAR4;PROKR2;CXCR4;ADGRL2;CCR10;ADGRD1;CRHR2;GPR75;GRM2;LGR4;HCRTR1;ADGRG2;ADGRG6;TPRA1;GPR63;GABBR2
prerank,solute:anion antiporter activity (GO:0140323),-0.4414932143053524,-1.1734737657470413,0.2680965147453083,0.646427722025678,1.0,2/14,1.56%,SLC7A11;SLC26A7
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5456129317472406,1.1703673594621846,0.29984301412872844,0.8875372824191657,1.0,2/13,8.87%,SREBF2;EHHADH
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5379171950171081,1.1698132717458796,0.2942097026604069,0.8834054497464631,1.0,5/13,19.16%,SLC66A1;SLC3A1;SLC7A6;SLC7A3;SLC38A7
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3669584947666645,-1.1697593156520216,0.21739130434782608,0.6475743668632441,1.0,9/25,17.58%,HIP1;TGFA;ERBB4;PLSCR1;LINGO1;GRB2;CNOT9;ATXN2;EGF
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4210664631851274,-1.1677857188202831,0.26861702127659576,0.644503725772019,1.0,3/16,5.61%,SLC13A3;SLC1A5;SLC1A1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.41823244049364,1.1621798580994285,0.2708074534161491,0.9027721669220675,1.0,21/57,21.44%,NDUFV1;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,protein kinase activator activity (GO:0030295),0.418122602414492,1.1589471579345187,0.2679012345679012,0.9077616310353159,1.0,11/60,10.17%,FGF13;DAXX;CDKN1A;WNT11;GPRC5A;EPO;ERBB3;IQGAP1;GPRC5D;MAP2K2;ABI1
prerank,omega peptidase activity (GO:0008242),0.39826667194147636,1.158523987801608,0.246311010215664,0.9031308181431488,1.0,25/89,18.28%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP10;USP32;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP21;USP16
prerank,endopeptidase inhibitor activity (GO:0004866),0.40448743984056096,1.1571828486591358,0.25754060324825984,0.9017682635095933,1.0,13/82,10.40%,COL4A3;SLPI;CRB2;SPINT2;NGF;TIMP4;SERPINC1;TIMP1;TIMP2;ANXA2;PSMF1;SERPINB8;CARD16
prerank,hyaluronic acid binding (GO:0005540),0.5594359967161637,1.156560424527864,0.3191126279863481,0.8979185580387927,1.0,3/10,8.15%,CD44;IMPG1;STAB2
prerank,endopeptidase activity (GO:0004175),0.3624312715863744,1.153912853873274,0.17617107942973523,0.9006951957436936,1.0,29/257,10.91%,DPP4;THSD4;ADAMTS14;PIK3IP1;MMP9;ADAMTS7;ADAMTSL5;ADAM10;HPN;ADAM33;USP46;USP29;PRSS12;USP10;PRSS36;GZMM;CTSZ;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1;PREP;KLK1;USP20;USP24;HP;HPR;USP42
prerank,endodeoxyribonuclease activity (GO:0004520),0.48924439992022417,1.151846666574134,0.31419939577039274,0.9018409609437935,1.0,8/20,19.88%,FEN1;MRE11;ERCC5;MBD4;ENDOV;DCLRE1C;RAD50;ERCC4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.44881730683242027,-1.151617234004808,0.27297297297297296,0.6783253666350865,1.0,6/12,16.25%,PIK3CB;PIK3R6;PIK3CD;PIK3R3;PIK3C3;IPMK
prerank,tRNA binding (GO:0000049),0.42640309220954725,1.1512354345504865,0.28894806924101196,0.8980329985610221,1.0,22/43,24.39%,EEF1A1;FARS2;ELP5;THG1L;AARS1;MRPS27;PSTK;SARS2;SARS1;TRNT1;TRNAU1AP;CTU1;EIF2AK4;DARS2;TRMT10B;HSD17B10;TYW5;YARS2;IGHMBP2;NSUN6;KARS1;EIF2A
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.34537756498545125,-1.1510073185754006,0.2661290322580645,0.6713981652670236,1.0,9/38,12.00%,PLA2G4A;HIP1;DENND1A;SH3PXD2B;DAB2IP;ZFYVE28;PLEKHA4;LANCL2;PLEKHF1
prerank,carboxy-lyase activity (GO:0016831),0.46881974463291404,1.15008248029156,0.30959302325581395,0.8959368099354971,1.0,10/23,22.88%,ECHDC1;AZIN1;UMPS;CSAD;PPCDC;PCK2;PISD;GAD1;UXS1;MLYCD
prerank,methyltransferase activity (GO:0008168),0.4245776127774207,1.1485517651954473,0.29246487867177523,0.8951428426101317,1.0,19/46,27.59%,CARNMT1;NTMT1;BUD23;GAMT;NNMT;AMT;EEF1AKMT3;MEPCE;PRMT1;ARMT1;COQ3;N6AMT1;TRMT11;LRTOMT;FTSJ1;MGMT;EHMT1;EEF1AKMT2;NDUFAF7
prerank,PDZ domain binding (GO:0030165),0.4031037655604741,1.147170448462632,0.27837514934289126,0.8936594614253182,1.0,7/61,9.59%,CXADR;CFTR;CRIM1;ARHGAP29;CXXC4;MAP2K2;LLGL2
prerank,semaphorin receptor binding (GO:0030215),0.4790200122878171,1.1462867363366582,0.30547550432276654,0.8909969375447973,1.0,3/23,2.81%,SEMA3D;PLXNB1;SEMA3B
prerank,lipoprotein particle receptor binding (GO:0070325),0.46674355240341686,1.1459208665285021,0.31129476584022037,0.8865728689938609,1.0,6/27,18.14%,CLU;APBB1;AP2A1;MESD;RELN;APBB3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.39639971119856493,1.1450456600825296,0.2596491228070175,0.8839195410778588,1.0,17/75,14.93%,GFUS;ADH7;DHRS4;IMPDH2;HMGCR;ME3;LDHB;PHGDH;PGD;LDHAL6B;EHHADH;AKR1B10;HADHA;HSD17B11;MDH2;HADHB;DCXR
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5429981367587678,1.1421755083015532,0.3016393442622951,0.8880906888772926,1.0,2/11,11.85%,SLC25A47;SLC25A45
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.48478892590816913,-1.1420967996216593,0.29198966408268734,0.6861752812393356,1.0,7/10,39.63%,DPYSL5;CAD;OPLAH;CRMP1;DPYSL4;DPEP1;DPYS
prerank,poly-pyrimidine tract binding (GO:0008187),0.47000461612979283,1.141200546095405,0.3148425787106447,0.8857934481908694,1.0,7/23,18.82%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2;PTBP1
prerank,damaged DNA binding (GO:0003684),0.42302106458681193,1.1394555563217255,0.28716645489199494,0.8860995738414281,1.0,15/44,19.88%,FEN1;EP300;CRY2;SDE2;ERCC5;RPA3;APTX;PCNA;DCLRE1C;DDB1;ERCC2;SMC6;NBN;PNKP;ERCC4
prerank,manganese ion binding (GO:0030145),0.4184638214323061,1.1387466740924732,0.29510309278350516,0.8830763962087371,1.0,6/48,5.72%,FAM20C;MPPED2;FEN1;GALNT1;LARGE1;MGAT1
prerank,"DNA binding, bending (GO:0008301)",-0.4310093966806143,-1.1385408209894798,0.28835978835978837,0.6866183628360718,1.0,5/14,17.01%,LEF1;SAP30L;HMGA2;HMGB1;HHEX
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.43807657484190393,-1.1331611741122265,0.30140845070422534,0.6927396138409246,1.0,5/13,10.15%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1
prerank,lipase activity (GO:0016298),0.4270948356272656,1.1331563984364472,0.30205655526992287,0.8962611997551424,1.0,4/43,4.98%,PLB1;ABHD5;PITPNM3;ABHD15
prerank,semaphorin receptor activity (GO:0017154),0.5292014116837871,1.1328629828412962,0.33762057877813506,0.8917832784478166,1.0,5/11,16.33%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3
prerank,mRNA methyltransferase activity (GO:0008174),-0.44438541315926494,-1.1309883983635163,0.3209549071618037,0.6895323400414004,1.0,3/12,10.23%,METTL8;METTL16;TRMT61B
prerank,death receptor activity (GO:0005035),0.5274125868191473,1.1295264364858941,0.3487603305785124,0.8972697193493852,1.0,3/11,9.01%,EDA2R;TNFRSF10B;TNFRSF1A
prerank,calcium channel inhibitor activity (GO:0019855),-0.4553236284691452,-1.1286087934793558,0.32682926829268294,0.6874301203330458,1.0,4/11,17.16%,ITPR1;SLC30A1;PACSIN3;FKBP1A
prerank,neuropeptide receptor binding (GO:0071855),0.5090985828431246,1.1243088830238779,0.35545023696682465,0.908497155372341,1.0,1/14,1.37%,GAL
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.40137484338803797,-1.123852071590474,0.33630952380952384,0.6917901422379065,1.0,10/18,25.62%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR;WDR81;AGAP2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4354497156446657,1.1237343604478853,0.322237017310253,0.9049784932343876,1.0,17/34,27.18%,EEF2KMT;DOT1L;SMYD3;EEF1AKMT3;SETDB1;SETD7;SMYD1;MEN1;ATPSCKMT;ANTKMT;KMT5A;KMT2E;N6AMT1;SMYD2;CAMKMT;EHMT1;EEF1AKMT2
prerank,steroid hydroxylase activity (GO:0008395),-0.4002065415930429,-1.1236129393457652,0.30835734870317005,0.6845169426490616,1.0,2/16,4.52%,CYP7B1;CYP1B1
prerank,poly(U) RNA binding (GO:0008266),0.46830865139900324,1.1215302088717158,0.31921331316187596,0.9070540554821465,1.0,6/20,18.30%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2
prerank,antiporter activity (GO:0015297),0.46869800846967136,1.1185161699582937,0.3174366616989568,0.9113554296349048,1.0,8/20,22.75%,SLC35D3;CLCN4;SLC25A14;SLC35E2B;SLC35E2A;ATP1A3;SLC35C2;SLC25A11
prerank,syntaxin-1 binding (GO:0017075),0.4732291166529161,1.1176069432367555,0.34146341463414637,0.9090279772752685,1.0,4/22,8.20%,UNC13C;SYP;DAPK1;STXBP1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5224363067169597,1.11690743408148,0.36304700162074555,0.9060179104789325,1.0,5/12,16.82%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A
prerank,ATPase activator activity (GO:0001671),-0.37869991793874214,-1.1109838387330528,0.28391167192429023,0.7091286231991915,1.0,8/20,24.18%,ATP1B1;DNAJB4;DNAJA1;DNAJC19;DNAJB2;DNAJC1;DNAJB1;AHSA1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.45175986095031484,-1.1098219859357596,0.3192019950124688,0.7039393229106378,1.0,3/11,14.11%,ITPR1;MCOLN1;RYR2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.46671362003029765,1.1068077556874696,0.3561643835616438,0.9326710711851128,1.0,5/20,10.17%,TJP2;CMPK1;AK3;AK6;CASK
prerank,histone deacetylase activity (GO:0004407),0.4707544733349545,1.1038797581089215,0.34,0.9369100174850931,1.0,5/19,17.34%,HDAC5;HDAC4;HDAC3;MIER2;HDAC6
prerank,protein kinase inhibitor activity (GO:0004860),0.40986774569427975,1.1035092304045342,0.32073011734028684,0.9327899858535612,1.0,13/42,19.02%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;CAMK2N1;SH3BP5L;TAOK3
prerank,cytokine receptor activity (GO:0004896),0.373351451169503,1.1033542478497813,0.3,0.9281002794980585,1.0,10/83,5.94%,CD44;CRLF1;CCR4;IL17RE;IL17RA;ACKR4;ACKR2;IL3RA;GFRA3;CCRL2
prerank,lysophospholipase activity (GO:0004622),0.46899239542409477,1.1031514571222898,0.35302806499261447,0.9235840353680665,1.0,1/20,0.17%,PLB1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4615803041411297,1.0983344399829433,0.36086956521739133,0.9337533615062994,1.0,4/22,10.11%,DUSP10;DUSP12;DUSP1;MTMR3
prerank,histone acetyltransferase activity (GO:0004402),0.42989852762086206,1.098278468303993,0.35956580732700133,0.9288137907327466,1.0,4/30,6.61%,NCOA3;EP300;NAA40;KAT6B
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5215565001566372,1.095648553843926,0.37372013651877134,0.9316923524906552,1.0,2/11,10.21%,PPP1R14B;PPP1R11
prerank,CoA hydrolase activity (GO:0016289),0.4902134755662101,1.095415503882813,0.3639240506329114,0.927351896912901,1.0,2/16,2.68%,ACOT8;ABCD1
prerank,transforming growth factor beta binding (GO:0050431),0.45026620512406157,1.0942413322150657,0.33770014556040756,0.9259833932861382,1.0,3/23,5.03%,CD109;TWSG1;LTBP4
prerank,small GTPase binding (GO:0031267),0.35141104317672833,1.092904235285901,0.3192834562697576,0.9250086147569131,1.0,40/170,16.14%,RNF152;STK19;SRGAP2;NDRG1;AKAP13;CAV1;CDC42EP4;EHD1;DAPK3;UNC13D;CDC42EP5;YBX3;MLPH;SH3BP4;RAB11FIP3;TSC2;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;DMXL2;MYO5A;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;WASF1;MAPKAP1;EXOC8;OCRL;CHML;ULK1;DNM1L;USP6NL;ARHGDIB;FLNA;RIN3
prerank,phospholipase activity (GO:0004620),0.38902901325395317,1.0908040287184058,0.33733493397358943,0.9263114705690708,1.0,6/67,7.23%,PLB1;PLCB3;NAPEPLD;PITPNM3;PLA2G12A;PLCL1
prerank,phospholipid transfer activity (GO:0120014),0.46116562518292314,1.0904465550297595,0.3559077809798271,0.9224669648057906,1.0,3/21,6.32%,PITPNM2;PITPNC1;PRELID3B
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5031968744039557,1.0903887363701392,0.35962145110410093,0.9177700574825837,1.0,1/12,0.78%,CYFIP2
prerank,RNA stem-loop binding (GO:0035613),0.5211448258565571,1.0902169392158065,0.38207547169811323,0.9134570416298555,1.0,4/12,15.32%,ZC3H12A;EPRS1;CPEB3;DHX9
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.417368117406137,-1.0876832991132566,0.37597911227154046,0.7553317694051084,1.0,7/13,21.98%,TARBP1;METTL1;TRMT10A;THUMPD2;TRMT5;TRMT1L;TRMT10C
prerank,cation transmembrane transporter activity (GO:0008324),0.39924856757218763,1.0868191656508577,0.35768261964735515,0.9192429449725725,1.0,16/48,20.85%,SLC36A3;SLC66A1;OCA2;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;PKD2L1;SLC41A1;SLC6A7;SLC7A3;SLC8B1;SLC38A7;SLC25A2;SLC38A6
prerank,protein kinase binding (GO:0019901),0.33593163504639867,1.0867090086254931,0.2595190380761523,0.9147499883248019,1.0,116/479,18.47%,PRKCB;UTRN;ANK2;DAXX;PDLIM5;TJP2;TRIB2;EPHA4;GRK5;CDKN1A;ADAM10;EMP2;CAV1;MAVS;NBEAL2;EEF1A1;HDAC5;QARS1;PRR7;FOXO3;RELB;AP2A2;DUSP10;CAVIN2;HSPB1;PPP1R15A;PIH1D1;DUSP1;CAV2;BCL2L1;RNF138;FOXM1;SPRED3;SOX9;SHC1;PFKFB2;CSK;MAPK7;MSN;CCND2;SYN1;TRIM21;BAD;ILK;LATS1;SRCIN1;ADCY6;PKD1;PARD6B;FZD5;LRBA;TCF7L2;IQGAP1;OXSR1;CDC42;ACSL3;FBXO5;CDK5RAP1;ACTB;PTPN6;EZR;CCND1;DACT2;SMCR8;NELL2;ZC3HC1;EXOC2;PKIA;MVP;AP2A1;SLC12A4;RHOA;YWHAZ;BCAR1;PPP1CB;JTB;PTPN2;MAPKAP1;KCNA5;PTN;PPM1D;MAP3K13;VDAC1;GSK3A;IRAK1;SHC2;PRKAR2A;GSK3B;CCDC88A;WNK1;DNAJC3;TNIP1;TNNI3;HSP90AA1;RB1CC1;ITGB2;PRKCSH;EEF2;FAM83H;AP1B1;CRK;ARHGAP33;ABL1;PRKAG1;NSF;CDC25B;MAPKAPK2;MTCP1;CDH5;CHEK2;DUSP3;PTPN11;CAMK2N1;SUFU;RARA;ATF2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.43290008503976307,-1.0865323896582668,0.3619791666666667,0.7500395404658816,1.0,6/12,20.09%,TENT5A;PAPOLA;PAPOLG;TENT5D;TENT2;PAPOLB
prerank,phosphatase activator activity (GO:0019211),0.4891229163196214,1.0802616357658354,0.39331210191082805,0.9299969539805513,1.0,2/14,4.99%,GTF2F1;PPP1R15A
prerank,retinoid binding (GO:0005501),-0.3638630150183709,-1.0744612198318568,0.34049079754601225,0.7750147900513604,1.0,3/22,5.05%,ALDH1A2;NR2F2;CYP26B1
prerank,LRR domain binding (GO:0030275),0.48170617481536504,1.073627446506999,0.3905996758508914,0.9451788591145114,1.0,4/14,14.30%,PAWR;DAPK3;LRRFIP2;ZXDC
prerank,RNA polymerase core enzyme binding (GO:0043175),0.43373633898222175,1.073128500985373,0.3739946380697051,0.9417523980231978,1.0,9/33,16.80%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2;SPTY2D1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.39084276130647877,-1.0724817930837838,0.3651226158038147,0.7719006873978611,1.0,12/15,50.60%,P2RY14;P2RY1;P2RY12;PTAFR;GPR34;P2RX5;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4047467263829581,1.0708006742097218,0.3608108108108108,0.9440700726530894,1.0,5/38,8.77%,SLPI;SPINT2;SERPINC1;ANXA2;SERPINB8
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3581601829192942,-1.0690310161172618,0.3790849673202614,0.7729016582738821,1.0,14/21,52.94%,GRM5;GRM1;CHRNB1;ANXA9;CHRNA4;CHRNB2;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1
prerank,voltage-gated anion channel activity (GO:0008308),0.48168672814509955,1.0689974525789332,0.40809968847352024,0.9448068270847979,1.0,6/15,15.05%,VDAC2;CLCN4;ANO6;VDAC1;GPR89B;GPR89A
prerank,glycerophospholipid flippase activity (GO:0140333),0.5006594105302105,1.068608390216069,0.405320813771518,0.9413238388592553,1.0,2/11,6.77%,ATP10A;ATP8B2
prerank,ribonuclease activity (GO:0004540),0.38174767344962907,1.0668454948410586,0.37957124842370743,0.9418624216704409,1.0,10/56,10.61%,CNOT6;ZC3H12A;KHNYN;RNASEL;ANG;TSNAX;EXOSC3;YBEY;RNASE3;LACTB2
prerank,chemoattractant activity (GO:0042056),0.432627727341295,1.0667021067704654,0.3974358974358974,0.9375800563252162,1.0,5/26,8.78%,CCL5;GDNF;BMP4;LGALS3;VEGFB
prerank,sequence-specific mRNA binding (GO:1990825),-0.43815546777780406,-1.0658906848367131,0.3848101265822785,0.7729924802939476,1.0,6/10,27.59%,DHFR;SHFL;LARP6;TYMS;FMR1;RBM24
prerank,leak channel activity (GO:0022840),-0.3673097580516636,-1.064997130209834,0.3436619718309859,0.7673043144604028,1.0,3/18,8.33%,KCNK2;KCNK5;PANX1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3371584163883995,-1.0640662282665767,0.356401384083045,0.762488774871667,1.0,4/29,5.61%,SLC13A3;SLC26A7;SLC1A5;SLC1A1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.36677724666042166,-1.063559152140476,0.37175792507204614,0.7561308640068876,1.0,4/19,7.83%,ITPR1;GRIN2A;GRIN2B;MCOLN1
prerank,guanyl ribonucleotide binding (GO:0032561),0.34150912449956894,1.0627477302019512,0.34755463059313213,0.944983406066054,1.0,47/196,19.24%,RAB17;PDE5A;MPPED2;MRAS;RAP1B;EEF1A1;RAP1A;RAB9B;ARL4A;CNGA2;ARL3;RHOQ;EIF2B2;NRAS;KRAS;RHEB;GLUD1;CNGB3;RAB3B;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;ARFIP2;RHOA;RABL3;CNGB1;ARF4;RHOU;RAB5C;TUBB2B;RAB1B;HRAS;ATL2;RAP2C;ARL8A;ADSS2;DIRAS2;RAB8B;SLC19A1;RNF112;RAB27A;RAB9A;RHOT2
prerank,retinoid X receptor binding (GO:0046965),-0.4392072881669578,-1.061853823880641,0.4076923076923077,0.7528925726232568,1.0,5/11,21.27%,TACC1;NSD1;PPARG;NR4A2;NRIP1
prerank,heme binding (GO:0020037),-0.2843939832162782,-1.0607455323147268,0.38011695906432746,0.7481315647622454,1.0,14/65,10.38%,GUCY1B1;NOS3;PTGIS;FLVCR2;NOX4;CYP1B1;CYP26B1;PTGS2;HEBP1;PGRMC2;JAK2;COX15;RSAD1;SDHC
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.42051152117003904,-1.0598903674133617,0.38544474393531,0.742870384830456,1.0,6/12,19.38%,PIK3R1;SH2B3;GAB2;BLNK;SH2B2;TRADD
prerank,active ion transmembrane transporter activity (GO:0022853),0.40473904886018247,1.0579924331518418,0.3949129852744311,0.9545794288097085,1.0,8/37,11.31%,SLCO2A1;ATP13A3;COX5A;COX8A;UQCRC1;COX7A2L;COX5B;SLC22A8
prerank,voltage-gated ion channel activity (GO:0005244),-0.3927998116494951,-1.0565430777858884,0.3858267716535433,0.7440375524526571,1.0,4/14,6.83%,KCND2;CACNA1E;PKD2;VDAC3
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.49790959000861335,1.0545489088329627,0.3933884297520661,0.960280501221027,1.0,5/11,17.31%,RBX1;UBE4A;UBR5;PRPF19;STUB1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3471488129267794,-1.0518866518539542,0.3741935483870968,0.7491438465457639,1.0,5/23,8.09%,HIP1;SH3PXD2B;CLVS2;SNX14;PLEKHA4
prerank,lysine N-methyltransferase activity (GO:0016278),0.44549726663777045,1.0517697169461346,0.43093093093093093,0.9644022615127307,1.0,9/20,27.18%,EEF2KMT;EEF1AKMT3;SETD7;ATPSCKMT;ANTKMT;KMT5A;SMYD2;EHMT1;EEF1AKMT2
prerank,titin binding (GO:0031432),0.4877047890530756,1.0500738865615011,0.40540540540540543,0.9649626490234409,1.0,1/13,1.06%,ACTN2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5039431559770746,1.0497690569154987,0.42598684210526316,0.9613676617733476,1.0,5/10,21.65%,EP300;NAA40;ATF2;USP22;HAT1
prerank,calcium-release channel activity (GO:0015278),0.45396655372879574,1.0467410577500875,0.4216133942161339,0.9660431978501274,1.0,5/17,13.39%,ITPR2;TPCN1;ITPR3;RASA3;TRPM2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5110133050933438,1.045865516910885,0.4444444444444444,0.963990799787769,1.0,4/11,13.91%,NAA40;NAA15;NAA20;NAA10
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.35235342226097455,-1.045691801193171,0.4,0.7577331712483323,1.0,8/21,38.36%,GRIK2;GLRB;CHRNB1;CHRNA4;CHRNB2;P2RX5;P2RX3;P2RX6
prerank,monocarboxylic acid binding (GO:0033293),0.45250329091981845,1.0448752664220498,0.43215339233038347,0.962176574791367,1.0,1/18,0.90%,NAPEPLD
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.43243302984165943,1.0433919817402049,0.42151162790697677,0.9618831615798095,1.0,5/24,6.25%,MKNK2;PTK2B;DAPK1;CAMKK1;PHKA2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.47591542273995024,1.042504968391905,0.44272445820433437,0.9598184864445538,1.0,4/13,15.34%,SH3BP4;CCDC88A;ITGB1BP1;ARHGDIB
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.36398309604808204,1.0423598512795784,0.40093240093240096,0.9557266051347655,1.0,16/72,10.89%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;TWF1;AVIL;ANXA2;KRIT1;JPH2;RAB35;GSDME;SNX18
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.49105480446881183,1.0422721660970478,0.43829113924050633,0.9514493932571892,1.0,4/12,19.85%,FOS;TBPL1;H3-3A;TBP
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.37957817777427605,-1.0411493747867797,0.40607734806629836,0.7620108896039234,1.0,1/15,0.46%,PLA2G4A
prerank,lysine-acetylated histone binding (GO:0070577),0.4454417642611676,1.040795804009157,0.41297935103244837,0.9465610627494792,1.0,7/20,17.90%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRD9;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),0.4454417642611676,1.040795804009157,0.41297935103244837,0.9465610627494792,1.0,7/20,17.90%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRD9;BRDT
prerank,nuclease activity (GO:0004518),0.3754146121053136,1.0401100490104482,0.3945068664169788,0.9441876182889326,1.0,17/52,23.60%,ZC3H12A;FEN1;RNASEL;MRE11;ANG;XRN2;RNASE3;DNASE1L2;ERCC5;DNASE1L1;REXO4;RNASE4;RNASE7;PNKP;N4BP2;MAP1S;APEX1
prerank,syntaxin binding (GO:0019905),0.37458858742230206,1.0395183556847876,0.3863912515188335,0.9413693403957107,1.0,19/61,17.46%,UNC13C;SYP;CACNA1A;BLOC1S6;DAPK1;STXBP1;VPS54;VPS11;PTPN2;NAPA;NAPB;VPS52;VPS18;SYT6;STX16;SYT12;ABL1;NSF;VAMP1
prerank,protein serine/threonine kinase activity (GO:0004674),0.3258638778539007,1.0392877819414819,0.4048582995951417,0.9377206563527151,1.0,74/335,17.86%,PRKCB;STK19;MAP3K8;PRKAA2;LIMK2;FAM20C;NRBP2;MAP3K5;GRK5;TSSK6;TSSK4;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;CAMKK1;STK39;SIK3;MAPK15;MAPK7;MAP3K4;CDK16;PLK3;ILK;LATS1;DYRK1B;STK16;OXSR1;MAPK9;AURKC;BCR;LMTK2;TRIO;RAF1;CASK;SRPK2;CDKL4;GRK2;PKMYT1;CSNK1E;MARK4;TGFBR2;EIF2AK3;SRPK1;MAP3K13;CDK2;GSK3A;IRAK1;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;PLK2;TESK1;AAK1;PAK6;TTK;ATR;PRKCZ;MAP3K6;MAPK6;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PRKCQ
prerank,microtubule binding (GO:0008017),0.331436064572976,1.0384376585185366,0.40103092783505156,0.9357555922529643,1.0,48/222,19.21%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;NDRG1;NDEL1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;KIF1C;EML2;KIF1B;MAP4;CLIP4;KRIT1;PSRC1;CETN3;CCDC181;CHP1;GAS2L1;EZR;HDGFL3;HOOK1;PAFAH1B1;MARK4;ABRAXAS1;OPA1;TPGS1;CCDC88A;GAPDH;DNM1L;MAP1LC3B;REEP4;KIF17;CAMSAP1;RMDN3;HDAC6;NUMA1;SUN2;FHDC1;KIF20B;RAE1;TUBGCP5;HOOK3
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.35502502857755847,-1.036788011394507,0.4117647058823529,0.7657662889748637,1.0,5/20,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,actin monomer binding (GO:0003785),0.4291759163284135,1.035315202209184,0.4125,0.9401358697708727,1.0,6/22,16.81%,COBL;LMOD3;TWF1;MYL4;PFN2;ABL1
prerank,phosphate ion binding (GO:0042301),-0.43839506340356305,-1.0347014694261447,0.45,0.7639164190696334,1.0,4/10,21.50%,RPH3A;PDE2A;PNP;ADSS1
prerank,gated channel activity (GO:0022836),0.46570940109173264,1.0343544669777005,0.43605546995377503,0.9386583855617947,1.0,6/14,21.05%,TMC6;TMC2;PACC1;TMEM63B;TMC4;TMEM266
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.318524079608899,1.029597141875037,0.411,0.9479372051600918,1.0,118/732,14.34%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;FOXN3;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZIK1;HOXA5;ZBTB17;RXRB;SOX9;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;SIX1;MAZ;JUN;POU3F1;TCF7L2;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,beta-tubulin binding (GO:0048487),0.40266821529197416,1.0286949695592673,0.42837078651685395,0.9461752929937495,1.0,2/31,3.65%,FGF13;GJB6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.39994754284376366,1.0279055920816933,0.43724696356275305,0.9400727855533468,1.0,13/34,23.40%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12;NDUFB10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.39994754284376366,1.0279055920816933,0.43724696356275305,0.9400727855533468,1.0,13/34,23.40%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12;NDUFB10
prerank,snRNA binding (GO:0017069),0.38573974252414733,1.0252401946627185,0.42028985507246375,0.9433687040472696,1.0,13/42,24.65%,LSM10;SNRNP70;LARP7;LSM4;DDX39B;SF3B3;MEPCE;HEXIM1;TUT1;PRPF8;GEMIN5;CDK9;SNRPB2
prerank,RNA polymerase II complex binding (GO:0000993),0.416465060881174,1.0249366247000995,0.42838196286472147,0.9400833220487248,1.0,8/32,15.55%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3321919217379,-1.0240311688484818,0.4589041095890411,0.7849218063874769,1.0,5/25,9.01%,ZC3HAV1;ART3;PARP14;PARP8;TNKS
prerank,FAD binding (GO:0071949),0.4206473957151266,1.0237250895386942,0.4485294117647059,0.9393394915683697,1.0,5/24,8.62%,MICAL2;CYB5R3;NQO2;MICAL1;CRY2
prerank,glutamate receptor binding (GO:0035254),-0.36518604175807196,-1.0227042151490657,0.38109756097560976,0.7811749846685005,1.0,4/17,4.94%,HIP1;GNAS;SHANK3;SHISA6
prerank,GTPase binding (GO:0051020),0.32770492340407636,1.0220878782603176,0.441207075962539,0.9400416448350587,1.0,42/195,15.66%,RNF152;STK19;SRGAP2;NDRG1;AKAP13;CAV1;EPRS1;CDC42EP4;EHD1;DAPK3;UNC13D;CDC42EP5;YBX3;MLPH;SH3BP4;RAB11FIP3;TSC2;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;DMXL2;MYO5A;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;WASF1;MAPKAP1;RASA1;EXOC8;OCRL;CHML;ULK1;DNM1L;USP6NL;ARHGDIB;HSP90AA1;FLNA
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.32478362744293565,1.0216198958568268,0.4484167517875383,0.9372064239455531,1.0,63/269,18.00%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;PRR7;ERLIN2;BAG1;NFKBIA;ELOB;PATZ1;POLR2A;DDRGK1;MUL1;ERBB3;UQCRC1;JUN;FZD5;RBX1;SLC22A18;PML;SUMO2;SUMO3;UBE2B;APBB1;ACTG1;HSPBP1;JAK1;YWHAZ;UBXN7;NPLOC4;PRKAR2A;GSK3B;DNM1L;WASHC1;MAP1LC3B;MDM2;SYT11;HSP90AA1;IKBKG;RNF31;UBE2N;CCDC50;TPI1;HM13;RPS27A;UBC;VCL;SMC6;SMAD5;STUB1;HDAC6;UBE2J1;CHEK2;PSMD1;USP25;STAM;TRIM37;TSG101
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4236788769357248,-1.0205541339257271,0.45560747663551404,0.7795037675180544,1.0,3/10,21.29%,NOX4;NCF2;CYBB
prerank,hydro-lyase activity (GO:0016836),0.38269839625039215,1.020364234413829,0.4092071611253197,0.9365792695579477,1.0,12/41,18.91%,ECHDC1;UROS;EHHADH;HACD4;ENO2;HADHA;ACO2;AUH;HADHB;ECHS1;PARK7;APIP
prerank,Notch binding (GO:0005112),-0.34542254665007754,-1.0196802971980556,0.4064327485380117,0.7748464826796136,1.0,6/22,13.64%,JAG1;MEGF10;DTX1;JAG2;NOTCH4;CCN3
prerank,exonuclease activity (GO:0004527),0.3797397952215283,1.0196767977621697,0.44387755102040816,0.9343996966759048,1.0,13/46,20.44%,CNOT6;ZC3H12A;FEN1;MRE11;XRN2;EXOSC3;POLG;REXO4;FAN1;DCLRE1C;RAD50;DXO;APEX2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.48954254964316135,1.01904764496994,0.45233968804159447,0.9322303098319128,1.0,4/10,27.15%,FEN1;DCLRE1C;APEX1;POLD1
prerank,microtubule motor activity (GO:0003777),0.37499659565568366,1.0189236345068504,0.4430538172715895,0.9286664924628202,1.0,6/51,6.66%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,BMP binding (GO:0036122),-0.4092729734907376,-1.0185572591183951,0.4323607427055703,0.7708084296674897,1.0,2/11,1.85%,ENG;GREM2
prerank,carbohydrate kinase activity (GO:0019200),0.4872222575387349,1.0179811152299691,0.4420529801324503,0.9273173842424096,1.0,4/11,17.14%,NAGK;HK1;GALK2;GNE
prerank,acylglycerol lipase activity (GO:0047372),-0.41445016537333584,-1.0178932509214234,0.42744063324538256,0.7658062188400531,1.0,5/11,17.24%,ABHD3;MGLL;LIPE;ABHD12;ABHD2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3904692638427447,-1.0177849998521042,0.42894736842105263,0.759463531904728,1.0,4/13,9.69%,PIP5K1B;PIP4K2A;PIK3CB;PIK3CD
prerank,receptor tyrosine kinase binding (GO:0030971),0.3632396845149192,1.017061031200807,0.4424019607843137,0.9257693490897285,1.0,6/56,7.75%,PITPNM2;ANGPT1;PTPN14;PITPNM3;SHC1;FIZ1
prerank,histone methyltransferase activity (GO:0042054),0.3993153570315341,1.0157841490946877,0.4366013071895425,0.9252859292621021,1.0,15/32,26.58%,NTMT1;DOT1L;SMYD3;SETDB1;PRMT1;PRMT2;SETD7;SMYD1;MEN1;KMT5A;KMT2C;KMT2E;N6AMT1;SMYD2;EHMT1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3137045685190195,1.0155121537589145,0.45,0.9221532774597117,1.0,118/731,14.34%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZIK1;HOXA5;ZBTB17;RXRB;SOX9;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;SIX1;MAZ;JUN;POU3F1;TCF7L2;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;TWIST1;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,RNA binding (GO:0003723),0.31253014984833233,1.013382201450317,0.438,0.924040418299428,1.0,320/1321,20.01%,MBNL1;MSI2;NUDT4;CELF2;NSA2;PPARGC1A;STRBP;AHNAK;VIM;LSM10;PABPC4L;SAMD4A;DDX5;CPEB2;GTF2F1;YTHDF1;ZC3H12A;SRSF2;SLPI;GRWD1;PABPC1L;EEF1A1;SAMD4B;CELF1;DGCR8;PEF1;EPRS1;DIAPH1;RBFOX2;CDC42EP4;CMSS1;CTNNA1;PCDH20;MRPL37;MRPL2;ACIN1;NOP2;YBX3;RBM19;PES1;HSPB1;TRIM25;PPAN;ADK;BUD23;MTDH;UTP11;FARS2;DMGDH;FDPS;KHNYN;SNRNP70;SON;CCDC9;SNRPB;RPS4X;UNK;EIF3L;TARBP2;USP10;SLTM;MRPS7;POLR2A;KIF1C;SRRM2;PKM;RNASEL;ADD1;SUCLG1;MOV10;TES;EIF4A3;SLIRP;ANXA2;UTP23;RBMS3;MAP4;PSMD4;MSN;SSRP1;FLNB;RBM20;DHX32;SMG7;SIDT2;NKAP;UNC50;KRR1;PRRC2C;ANG;RALY;MAK16;TSNAX;LARP7;LSM4;POP4;ABCF1;STXBP1;LGALS3;L1TD1;MAZ;JUN;ELP5;UBTF;DDX39B;RBM8A;XRN2;RPL31;RPSA;EXOSC3;EIF4B;HNRNPH2;SUMO2;POP1;GSPT2;WDR33;RPL22;MOV10L1;ERI3;GTPBP10;MYO5A;AGFG1;EZR;THG1L;PHF5A;AARS1;DBR1;MRPS23;ILF2;RRP12;LUC7L3;BMS1;DDX55;SRPK2;NIP7;MTREX;DHX57;MRPS27;WDR43;KHDC4;LACTB2;SRRM4;R3HDM2;HABP4;PLEC;WDR36;RPL28;CSNK1E;ZMAT3;TBRG4;PWP2;SRSF7;ANKRD17;MDH2;DDX47;SRBD1;YWHAZ;SF3A2;ZCCHC24;FASN;RPS26;POLDIP3;EIF4G2;RBM42;PSTK;MRPL9;NAA15;WDR6;RPP21;ZCCHC8;CPEB3;FRG1;FAM133B;SRPK1;HNRNPUL1;GPATCH1;SYNCRIP;GAR1;GOLGB1;CHD3;TUT7;IBA57;CCDC9B;FXR1;RBM10;NOC4L;DAZAP1;LGALS1;RNPS1;HARS2;PNN;RPL10A;REXO4;R3HDM1;NOL6;PINX1;RRP9;CSTF1;TPD52L2;LTA4H;FNDC3A;SRSF9;MRPS15;DCP1A;SRRT;TNPO1;SARS2;SARS1;DUS2;UPF3B;EIF4G1;ALDOA;TRNT1;ENDOV;YARS1;PYM1;RPF1;ZFR2;HADHB;RBM18;UTP14A;APTX;GRSF1;EIF4A1;RBM46;DDX18;TLR3;UTP4;ISY1;FBRSL1;DHX9;EIF5B;HSP90AA1;EIF3B;TRNAU1AP;MBNL2;PABPN1;RBM47;OAS2;IMMT;IMP4;LUC7L2;CCDC47;ACTN4;FLNA;CWC15;FSCN1;UBE2N;MEPCE;MRPS28;MRPS35;CDC5L;RPL14;DUSP11;MEX3D;RRBP1;MAGOHB;MAGOH;EEF2;RBPMS2;ATXN2L;ARHGEF1;CANX;EIF1;CTU1;RPS27A;UBC;PRR3;HEXIM1;SELENOH;RBM28;KDM1A;PRPF40B;DYNC1H1;EIF2AK4;ZYX;PRMT1;ASS1;PRPF6;FARSA;EIF4A2;CLUH;PATL1;PDCD11;SEC23IP;HNRNPA3;PPP1R10;IGF2BP3;IMP3;RBMS2;SRSF1;PARK7;RAE1;SNUPN;UBAP2L;YTHDF3;ROCK2;DARS2;PTBP1;SRSF5;IGF2BP2;UBFD1;TRMT10B;RPL6;MYO18A;ALDH18A1;HDGF;PCBP2;NUCKS1;GCN1;DXO;CSTF3;TRUB2;CDK11B;ANKHD1;WBP4;SF3A3;RPS28;DDX20;HSD17B10
prerank,potassium channel regulator activity (GO:0015459),-0.2814445306653311,-1.0098774619890925,0.4166666666666667,0.7722738611550938,1.0,10/49,16.57%,DPP10;SGK1;ABCC9;KCNIP4;WNK2;KCNIP3;KCNIP1;DPP6;KCNMB4;SLC5A3
prerank,ion channel inhibitor activity (GO:0008200),0.3917635137767758,1.0098448124911477,0.4604904632152589,0.9295814238462367,1.0,7/35,15.15%,CFTR;MCUB;VTI1B;RASA1;WNK1;NEDD4;TNNI3
prerank,actinin binding (GO:0042805),0.4225720112948104,1.0079077158362815,0.45911047345767575,0.9309112121558345,1.0,6/21,12.56%,PDLIM5;DAG1;CSRP3;MYOT;PKD2L1;KCNA5
prerank,phosphoric diester hydrolase activity (GO:0008081),0.387682996403884,1.006050372659525,0.4635135135135135,0.9321930844668316,1.0,3/35,1.74%,PLCB3;NAPEPLD;MPPED2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.41080796222449284,1.0054134735747278,0.45375722543352603,0.9302119456414812,1.0,7/26,15.10%,PPP1R14B;LGALS3;LMTK2;PPP1R11;PTN;SET;PPP1R1B
prerank,diacylglycerol kinase activity (GO:0004143),-0.4076167096332786,-1.004977898072033,0.4802955665024631,0.7785558526258702,1.0,7/11,23.01%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,CCR chemokine receptor binding (GO:0048020),0.4038220337812998,1.0043412401560665,0.4594972067039106,0.9292847069685072,1.0,2/28,5.94%,CCL5;CCRL2
prerank,ribosomal large subunit binding (GO:0043023),0.4902920172416369,1.0034151962029259,0.48360655737704916,0.927793613826219,1.0,3/11,9.96%,CPEB2;EIF6;LTN1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3001904921609935,-1.0023380262593595,0.42063492063492064,0.7781289963927003,1.0,10/34,17.84%,STK3;IGF2;STRADA;ETAA1;IRGM;ALS2;FAM20A;DBF4;INCENP;MAP2K1
prerank,poly(A) binding (GO:0008143),0.41522525278002714,1.0018934367060943,0.4302496328928047,0.9281430314023952,1.0,4/21,6.96%,PABPC4L;PABPC1L;EIF4A3;RBMS3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3694626921700356,1.0013572580207952,0.4441591784338896,0.9258646668917829,1.0,16/49,23.33%,MINDY2;IKBKE;OTUD7B;PSMD4;TAB3;AGAP3;ABRAXAS1;ZFAND6;TNIP1;IKBKG;HDAC6;TAB2;PRPF8;RNF168;UBQLN2;RNF169
prerank,endoribonuclease activity (GO:0004521),0.3946203540438355,1.0013243633038895,0.44163150492264414,0.9222114141582785,1.0,7/32,14.48%,ZC3H12A;KHNYN;RNASEL;TSNAX;YBEY;LACTB2;ENDOV
prerank,Hsp90 protein binding (GO:0051879),-0.303858327259605,-0.9984488814431534,0.425531914893617,0.7815642456669528,1.0,7/33,9.24%,PACRG;HIF1A;KDR;TSC1;SLC12A2;NPAS2;HSF1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4121241598707557,-0.9971466400149329,0.4897959183673469,0.7782545631361667,1.0,6/11,10.96%,ITPR1;TRPC3;TRPC4;RPH3A;TRPC6;TRPC5
prerank,metalloexopeptidase activity (GO:0008235),0.36719026820600725,0.9966928264498742,0.45760598503740646,0.9307096507052298,1.0,6/51,7.95%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,transferrin receptor binding (GO:1990459),0.4840809896672748,0.9960994573012983,0.4846938775510204,0.9285635364276331,1.0,7/10,28.08%,CD81;CHUK;IKBKG;IKBKB;SNX2;HFE;SNX4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.4357993974439657,0.9953254723443814,0.4774494556765163,0.923156142986416,1.0,11/16,31.11%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.4357993974439657,0.9953254723443814,0.4774494556765163,0.923156142986416,1.0,11/16,31.11%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,sodium channel regulator activity (GO:0017080),0.38718925223324385,0.9933291144193299,0.49022164276401564,0.9246915739323418,1.0,2/37,3.69%,FGF13;SGK3
prerank,gamma-tubulin binding (GO:0043015),0.4230665960143852,0.9910808377892966,0.47763347763347763,0.9266840012247406,1.0,7/21,18.91%,NDRG1;DIXDC1;RAB11FIP5;MARK4;BLOC1S2;GIT1;TUBGCP5
prerank,SH3 domain binding (GO:0017124),0.3542031910779571,0.9908295805420333,0.4777911164465786,0.9237079855607362,1.0,10/62,10.44%,ADAM12;ENAH;ESPN;MAPK15;AFAP1;AFAP1L1;MICAL1;ABI1;AKAP5;ADAM15
prerank,ubiquitin protein ligase binding (GO:0031625),0.3163678316796628,0.9901771878857707,0.5030800821355236,0.921720969873928,1.0,59/254,18.00%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;ERLIN2;BAG1;NFKBIA;ELOB;PATZ1;POLR2A;MUL1;ERBB3;UQCRC1;JUN;FZD5;RBX1;SLC22A18;PML;SUMO2;UBE2B;APBB1;ACTG1;HSPBP1;JAK1;YWHAZ;UBXN7;NPLOC4;PRKAR2A;GSK3B;DNM1L;WASHC1;MAP1LC3B;MDM2;SYT11;HSP90AA1;IKBKG;RNF31;UBE2N;CCDC50;TPI1;HM13;RPS27A;UBC;VCL;SMC6;SMAD5;STUB1;HDAC6;UBE2J1;CHEK2;PSMD1;USP25;TRIM37;TSG101
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4122300631367002,-0.9897004689555335,0.4884910485933504,0.7893654000191433,1.0,3/10,8.63%,SLC6A13;SLC6A12;SLC6A1
prerank,adrenergic receptor binding (GO:0031690),-0.3608033359899803,-0.9892324327814369,0.4485981308411215,0.7839770766834383,1.0,3/16,1.74%,RAPGEF2;GNAS;PDE4D
prerank,tubulin binding (GO:0015631),0.31261122324262963,0.9885635489679306,0.4969450101832994,0.9221756463483247,1.0,61/295,18.91%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;DAG1;NDRG1;DIXDC1;NDEL1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;AGTPBP1;KIF1C;EML2;KIF1B;MAP4;KRIT1;AGBL1;GPAA1;PSRC1;CETN3;CCDC181;CHP1;GAS2L1;EZR;HDGFL3;HOOK1;BCAS3;PAFAH1B1;RAB11FIP5;EFHC2;MARK4;ABRAXAS1;BLOC1S2;OPA1;TPGS1;ALDOA;CCDC88A;GAPDH;DNM1L;WASHC1;MAP1LC3B;ARL8A;REEP4;KIF17;CAMSAP1;RMDN3;GIT1;HDAC6;RITA1;NUMA1;SUN2;FHDC1;KIF20B;RAE1;TBCE;TUBGCP5
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.397150367442396,0.9844452855979537,0.47688243064729197,0.9288882222443948,1.0,8/33,15.55%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.37604840753506413,0.9826287472364591,0.49195710455764075,0.9299365898573609,1.0,3/38,6.53%,SORBS1;MAGI2;SHC1
prerank,adenylate cyclase binding (GO:0008179),-0.4154420842226456,-0.9817021091808098,0.4897435897435897,0.795392694647304,1.0,3/10,17.44%,ADCY5;CAP2;ADCY2
prerank,double-stranded DNA binding (GO:0003690),0.3050459128864115,0.9814001065071782,0.5601202404809619,0.9294646308661624,1.0,114/531,21.82%,NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;GLI3;HOXA4;HIVEP1;KLF12;FEN1;FOXO3;FOS;FOXC2;GLIS2;KLF16;CGGBP1;NR6A1;FOXD2;POU2F3;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;MRE11;SOX9;ZBTB7B;MEF2D;CENPS;SIX1;JUN;POU3F1;FOXP3;NR2C1;ZIC1;HDGFL3;NFIB;NFIC;SP2;CREB3L4;CREB3;MEF2B;HOXB5;MAFG;SP1;FOXK1;TFEB;ERCC5;GATA3;ZNF177;REXO4;ZFP1;MEF2C;PAX3;FOXP1;IRF2;APTX;DHX9;MBNL2;KLF6;HMBOX1;E2F1;POU4F1;ABL1;CAMTA2;SMAD5;HSF2;DMRTA1;MEOX2;RAD50;RARA;PARK7;ATF2;HOXA9;NFKB2;ZBTB26;KLF2;HDGF;PNKP;ZBTB7A;NUCKS1;TEAD1;USF1;SREBF1;NFAT5;MAPT;SOX4;ZBTB32;IRF6;ZBP1;HOXA1;ELF1;KLF10;TERF2;MTF1;UBP1;YY1;YBX1;GABPA;ARNT;HOXA2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.30455407207597684,0.9806986526020857,0.5435435435435435,0.9277370940984084,1.0,83/597,14.34%,BNC2;NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;SMAD6;GLI3;HOXA4;HIVEP1;GABPB1;GABPB2;KLF12;GRWD1;HDAC5;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;FOXD2;POU2F3;BEND3;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;SOX9;ZBTB7B;MEF2D;SIX1;JUN;POU3F1;TCF7L2;CRY2;FOXP3;BRD7;NR2C1;ZIC1;NFIB;NFYC;ARID4A;NFIC;SP2;ZW10;CREB3L4;CREB3;NCOR1;CALCOCO1;MEF2B;HOXB5;MAFG;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3;MBD4;MLH3;ZNF177;ZFP1;MEF2C;PAX3;FOXP1;IRF2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.39782151430921825,-0.9805409633189557,0.45866666666666667,0.7917141921100576,1.0,2/11,0.54%,SH3RF1;KSR1
prerank,protein homodimerization activity (GO:0042803),0.3047630681868037,0.9804029947459885,0.558,0.9248138327095169,1.0,115/589,18.80%,CUBN;DPP4;FGFR1;NECTIN3;SRGAP2;CCL5;MAP3K5;PDGFC;ADAM10;FOXP2;S100A6;GDF15;ABCD1;STARD3;DGCR8;TIMM10;EPRS1;S100A10;DAPK3;GDNF;BLOC1S6;CARNMT1;NR6A1;ZBTB16;HSPB1;HARS1;CRYAB;S100A11;TARBP2;RAB11FIP3;IRF3;TSC2;CAV2;BCL2L1;HSPB8;ADD1;NRF1;ZBTB7B;NADK2;GLB1;PSMF1;NQO2;TRIM21;TGFB2;ANG;GALE;HPGDS;CHMP4A;CHMP4B;PML;TMEM192;FOXP3;KMT2A;SHMT1;EXT1;HOOK1;NFS1;ATP5IF1;CR2;PSMD7;PDK2;S100A1;PON3;VPS4B;RABL3;SP1;PHETA2;ERCC5;FXR1;MAP3K13;PAXX;CHMP1A;SLC39A13;FLRT3;IRAK1;SYT6;PHETA1;BNIP3L;CHUK;SARS1;CCDC88A;NAGA;SDCBP2;DNM1L;DNTTIP1;ABCB9;HSP90AA1;IKBKG;SPPL2B;ACTN4;FLNA;GSTM2;TPI1;RBPMS2;TPD52;TBC1D22A;HM13;SLC8B1;FICD;RAP1GAP;STUB1;CHEK2;PDCD6IP;SPPL3;BMPR1A;TRIM37;PDXK;TSG101;HMGCS1;SPPL2A;PARK7;KIF20B;PDLIM4;TOX3;DARS2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.43597267032555753,0.9803224359849821,0.49923195084485406,0.9215012955899111,1.0,2/17,2.68%,ACOT8;ABCD1
prerank,mRNA binding (GO:0003729),0.31045690974556917,0.9794377054910989,0.5420560747663551,0.9202034133295136,1.0,62/249,20.23%,CELF2;PABPC4L;SAMD4A;DDX5;CPEB2;YTHDF1;ZC3H12A;SLPI;PABPC1L;SAMD4B;CELF1;RBFOX2;YBX3;KHNYN;SNRNP70;UNK;MRPS7;SRRM2;PKM;EIF4A3;UTP23;RBMS3;RBM20;RBM8A;SHMT1;LUC7L3;SRRM4;SRBD1;RPS26;EIF4G2;CPEB3;SYNCRIP;FXR1;DAZAP1;CARHSP1;RNPS1;BOLL;AUH;DCP1A;UPF3B;EIF4G1;GRSF1;EIF4A1;RBM46;DHX9;RBM47;LUC7L2;RBPMS2;CLUH;IGF2BP3;RBMS2;SRSF1;PARK7;YTHDF3;PTBP1;SRSF5;IGF2BP2;PCBP2;DXO;CSTF3;ETF1;RPL41
prerank,calcium ion binding (GO:0005509),0.30854057833302845,0.9791614990556986,0.547112462006079,0.9174128634669203,1.0,41/323,12.09%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;ANXA8;ANXA8L1;GSN;S100A6;S100A10;OTOF;PITPNM3;ANXA4;LTBP4;S100A11;ANXA5;FBLN1;ANXA2;MICU1;DSC3;DSC2;HPGDS;CETN3;IQGAP1;CALR3;CHP1;PCLO;PCDHA4;ITPR3;DNASE1L2;NDUFAB1;S100A1;TRPM4;PKD2L1;LETM1;CALU;PLSCR3;CDH4;MMP12
prerank,cytochrome-c oxidase activity (GO:0004129),0.4361085611645241,0.9736912437523,0.4798061389337641,0.9272187773030364,1.0,4/15,10.27%,COX5A;COX8A;COX7A2L;COX5B
prerank,histone demethylase activity (GO:0032452),0.3885634953445504,0.970055143268209,0.5201109570041609,0.9327862671290327,1.0,7/27,12.10%,KDM4D;KDM4B;KDM5C;KDM3A;RIOX2;KDM4C;KDM6A
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4703059369859285,0.970021980408919,0.5160202360876898,0.929379818329979,1.0,3/10,10.86%,KDM4B;RIOX2;KDM4C
prerank,RNA cap binding (GO:0000339),0.4267055223830516,0.9675252144286247,0.4961948249619482,0.9318527428540636,1.0,1/16,0.78%,CYFIP2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.40992342593439324,-0.9657002219897002,0.48663101604278075,0.8219143677523034,1.0,6/10,23.81%,STAMBPL1;TNFAIP3;OTUD5;ATXN3;CYLD;YOD1
prerank,anion channel activity (GO:0005253),0.3393334248410531,0.9627907183548936,0.5073349633251834,0.940110295088092,1.0,12/61,15.05%,CFTR;ANO7;VDAC2;CLIC1;CLCN4;SLC1A4;ANO6;VDAC1;ANO3;CLCC1;GPR89B;GPR89A
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.29841535412105946,0.9625874751253227,0.635,0.937190828749649,1.0,126/831,14.34%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;TFAP2D;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZNF436;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;ZBTB8A;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;SOX9;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;CIC;SIX1;MAZ;JUN;POU3F1;TCF7L2;ZFP57;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;TWIST1;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZNF177;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.40345792868367114,0.9601888938741899,0.5179856115107914,0.9361223308171208,1.0,6/21,13.18%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.40345792868367114,0.9601888938741899,0.5179856115107914,0.9361223308171208,1.0,6/21,13.18%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.42278140085387134,0.9590561813283313,0.5375191424196019,0.9353511420107359,1.0,1/18,3.45%,HSD17B14
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.4671874190322601,0.958744732587369,0.5278246205733558,0.9327044687120384,1.0,1/10,0.70%,SLCO2A1
prerank,amino acid binding (GO:0016597),-0.2976187103300691,-0.9585488864660434,0.5436507936507936,0.8331107136919846,1.0,19/31,36.31%,NOS3;GRM7;GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;THNSL2;CASTOR1;CAD;GRIN3A;AARS2;SHMT2;GRIN1;GLDC;GCLC;GNMT;NOS2
prerank,rRNA binding (GO:0019843),0.3597022807961445,0.9568885685431819,0.5,0.9336276689745451,1.0,7/42,15.51%,PPAN;MRPS7;UTP23;ANG;MRPS27;MDM2;MRPS18C
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4198213960670424,0.9557952443938836,0.5198776758409785,0.9328344091729298,1.0,4/16,17.47%,ALOX5;TDO2;CDO1;HAAO
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.30590814693891283,0.9539175755621013,0.5699152542372882,0.9340290835938775,1.0,36/181,15.64%,KLF4;PPARGC1A;NCOA3;EP300;HDAC5;FOS;HDAC4;NFE2L2;ANXA4;WWP2;HSPB1;MTDH;SMARCB1;NFKBIA;CREB1;DDRGK1;COMMD7;FIZ1;JUN;TCF7L2;FOXP3;ACTB;BCAS3;HDAC3;COMMD6;SMARCA4;NCOR1;SP1;MIER2;PIAS1;PIAS3;MKKS;GSK3B;NCOR2;DHX9;ACTN4
prerank,death receptor binding (GO:0005123),0.4281045260257617,0.9497203801998908,0.5159744408945687,0.9404074531669545,1.0,3/15,10.99%,EDA;NGF;FEM1B
prerank,neurexin family protein binding (GO:0042043),0.4681861155158708,0.9480488051402735,0.5567190226876091,0.9410949203751496,1.0,2/10,7.07%,SYTL4;CPE
prerank,organic anion transmembrane transporter activity (GO:0008514),0.31236224088547965,0.9472562881890094,0.5769644779332616,0.9395372872802585,1.0,24/134,15.33%,CFTR;SLCO2A1;SLC36A3;SLC35D3;SLC16A11;SLC66A1;OCA2;CTNS;SFXN3;SLC36A4;SLC3A1;SLC2A8;SLC25A1;SFXN1;SLC25A38;SLC1A4;SLC25A17;SLC25A21;PDPN;SLC26A4;SLC6A7;SLC19A2;SLC25A12;SLC7A3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.42960271714626075,0.947064961040538,0.543613707165109,0.9365788122956058,1.0,4/15,7.99%,VEPH1;PHLDA3;RUBCNL;JPH2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2892770757930986,-0.9462997492694378,0.5305466237942122,0.8571483746317377,1.0,7/30,12.48%,SLC30A10;SLC39A12;SLC40A1;SLC39A8;SLC39A10;TTYH1;SLC30A1
prerank,sequence-specific DNA binding (GO:0043565),0.2947673945467937,0.9459488490558847,0.6566566566566566,0.9357463324326828,1.0,72/590,12.94%,NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PPARGC1A;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;FOXD2;POU2F3;ESRRB;RARG;RFX7;IRF3;PRRX2;SLTM;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;SOX9;FOXD1;ZBTB7B;MEF2D;UPF3A;SMG7;SIX1;JUN;POU3F1;TCF7L2;CXXC4;GRHL2;FOXP3;KMT2A;NR2C1;ZIC1;NFIB;NFIC;SP2;CREB3L4;CREB3;CALCOCO1;MEF2B;MMP12;HOXB5;MAFG;SP1;ZNF148;MAFK;FOXK1;TFEB;GATA3
prerank,ATP binding (GO:0005524),0.29524026580722934,0.9456733555084792,0.6061224489795919,0.933168156568738,1.0,84/266,22.53%,PRAG1;MAP3K5;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;HSPA14;LMTK2;MOV10L1;THG1L;AARS1;AK6;SRPK2;MTREX;ABCA2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;SARS2;EIF4G1;TRNT1;WNK1;CDC42BPA;ABCB9;DHX9;HSP90AA1;OAS2;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;PRKAG1;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;DARS2;ABCB6;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;ATP1A3;ATP1A1;WNK4;YARS2;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1
prerank,protein heterodimerization activity (GO:0046982),0.3065845431726915,0.9447837353161567,0.592436974789916,0.9320051001112163,1.0,26/178,14.72%,ADRA1B;AGTR1;HEXA;ATP1A2;PGLYRP3;PEF1;PPP2CA;BUD23;BCL2L1;ADD1;PSMF1;MICU1;ERBB3;TLR6;EXT1;KCNB1;PAFAH1B1;TLR4;SAE1;GABBR2;FXR1;TUBB2B;IRAK1;MEF2C;CHUK;SDCBP2
prerank,protein phosphatase binding (GO:0019903),0.31257024221602864,0.9433372810301125,0.5659760087241004,0.9320722070068765,1.0,22/117,12.95%,MAP3K5;ANK1;GTF2F1;IKBKE;PPP6R3;SH3RF2;AP3B1;PPP1R15A;ROS1;PXN;SMG7;BAD;LGALS3;IQGAP1;PPP1R16A;MTMR3;PPP1R11;AKAP5;JAK1;MVP;EIF2AK3;ANAPC4
prerank,dynactin binding (GO:0034452),0.4372241344591458,0.9428949310072648,0.5143769968051118,0.9298797405433885,1.0,4/12,20.10%,PAFAH1B1;GSK3B;HOOK3;MAPT
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.4306234394783568,0.9427728820662165,0.5434782608695652,0.9269130065766898,1.0,1/12,0.98%,CNOT6
prerank,tau protein binding (GO:0048156),0.3538015856330183,0.9421452816869821,0.5433376455368694,0.9251658413839741,1.0,12/40,18.79%,CLU;EP300;PPP2CA;ACTB;MARK4;GSK3A;GSK3B;PPP2CB;HSP90AA1;STUB1;HDAC6;ROCK2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.38822487488942836,-0.9414572319306499,0.5255102040816326,0.8621778896933309,1.0,4/11,16.11%,SLC35B3;LRRC8A;SLC25A25;SLC25A23
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.390509894549978,0.9401754971837265,0.5567010309278351,0.9266011562612004,1.0,5/22,15.91%,CPEB2;ZC3H12A;RBMS3;CPEB3;MEX3D
prerank,serotonin receptor activity (GO:0099589),0.3952402287311891,0.9393774228798989,0.5311203319502075,0.918926745805579,1.0,1/22,0.76%,CHRM1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3952402287311891,0.9393774228798989,0.5311203319502075,0.918926745805579,1.0,1/22,0.76%,CHRM1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3952402287311891,0.9393774228798989,0.5311203319502075,0.918926745805579,1.0,1/22,0.76%,CHRM1
prerank,I-SMAD binding (GO:0070411),0.4339138061909803,0.9387304146419613,0.5275590551181102,0.9173749240283365,1.0,2/13,7.68%,SMAD6;TGFB1I1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.42725258935856725,0.9376753822272519,0.5232919254658385,0.9167120866571224,1.0,3/13,6.81%,GDF15;BMP5;BMP4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.26587503279021274,-0.9339956968580336,0.5775862068965517,0.8739897822702931,1.0,7/44,10.14%,MECOM;SETD5;PRDM16;NSD1;EZH2;RBBP5;NSD3
prerank,pyrophosphatase activity (GO:0016462),-0.25554690244178657,-0.9338386121867471,0.5707547169811321,0.867632758327867,1.0,20/50,23.18%,ENPP1;ENTPD1;ALPL;PPA1;ITPA;ENPP3;LHPP;PRUNE1;PPA2;ATCAY;PRUNE2;DHX29;DOLPP1;NUDT1;ENTPD3;ENTPD5;ENTPD6;CILP;FITM2;NUDT16
prerank,BMP receptor binding (GO:0070700),0.42725685341528447,0.9335884865388953,0.5446009389671361,0.9226316867673059,1.0,3/12,6.81%,GDF15;BMP5;BMP4
prerank,thyroid hormone receptor binding (GO:0046966),0.37838545882384395,0.9335579764396978,0.5308988764044944,0.9195853584956463,1.0,6/28,13.64%,NCOA3;MED30;GAS2L1;NCOR1;MED12;MED24
prerank,SH2 domain binding (GO:0042169),-0.2899771122193729,-0.9335441597025514,0.5567765567765568,0.8617414423885862,1.0,11/31,18.47%,AFAP1L2;SH3PXD2B;PTK2;PAG1;JAK2;BLNK;RACK1;RUFY1;SKAP1;SH2B2;INPPL1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.29726228665848126,0.9320220284466473,0.5887265135699373,0.9200046365560256,1.0,29/188,12.94%,BNC2;KLF4;PBX1;SMAD6;GABPB1;GABPB2;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;JUND;SIX1;JUN;TCF7L2;CRY2;BRD7;NFYC;ARID4A;NCOR1;CALCOCO1;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3
prerank,myosin binding (GO:0017022),0.33235490789965705,0.9315227306679457,0.5618247298919568,0.9180368231093855,1.0,10/55,13.56%,CALD1;GSN;CXCR4;MLPH;NCKIPSD;RAB3B;LMTK2;LLGL2;RHOA;ARFGEF1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.29641224957294177,0.9301432178494708,0.6350515463917525,0.917899134410971,1.0,48/232,17.78%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;CBLL1;TRIM41;TRIM21;RBX1;CDC42;TRIM26;TRIM11;RNF121;LTN1;PPP1R11;SIAH3;COP1;VPS11;NSMCE2;RNF126;PIAS1;PIAS3;DTX3;PELI1;CBX4;VPS18;BRAP;UBR5;NEDD4;MDM2;BFAR;MSL2;PRPF19;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;PDZRN3;TRIM37
prerank,motor activity (GO:0003774),0.3334353968559969,0.9278189659173335,0.5719467956469165,0.9199856636730648,1.0,6/60,6.66%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,inward rectifier potassium channel activity (GO:0005242),-0.3008397356990332,-0.9259068722040742,0.5625,0.8744979838211148,1.0,10/24,25.53%,KCNN2;ABCC9;KCNJ2;KCNJ12;KCNJ6;KCNJ10;KCNJ8;KCNJ15;KCNK1;KCNJ3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.373139490069882,-0.9220266392387569,0.5655737704918032,0.8774632670996957,1.0,5/12,21.07%,SLC35B3;LRRC8A;SLC25A25;SLC25A23;SLC25A5
prerank,translation initiation factor activity (GO:0003743),0.35734978774288195,0.9215750664900968,0.5659863945578232,0.9302941798939521,1.0,13/36,17.44%,EIF3L;EIF2B2;EIF3K;EIF4G2;COPS5;EIF3M;EIF4G1;EIF4A1;EIF5B;EIF3B;EIF1;EIF2B4;EIF4A2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3176922258443072,0.9186748017163056,0.5906432748538012,0.9334893269792648,1.0,13/74,10.64%,FAM20C;ADK;PIK3C2B;AGK;PKM;NT5C3A;NADK2;DCAKD;TRPT1;NADK;PI4KA;HK1;DGKA
prerank,ligand-gated cation channel activity (GO:0099094),-0.23276260107205438,-0.9146179588247392,0.6956521739130435,0.8884177769855488,1.0,15/75,14.60%,GRIK2;KCNN2;GRIN2A;GRIA3;GRIA2;GRIN2B;KCNJ2;GRIK3;MCOLN1;GRIK1;GRIK4;KCNJ12;CCDC51;KCNJ6;KCNJ10
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3181675406877553,0.9145452298688381,0.5760095011876485,0.9396062244247706,1.0,23/71,18.01%,PTPN14;EYA2;PTPRU;PTPRD;DUSP1;PTPRF;EYA1;PTPN9;PTPRA;PTPN6;MTMR3;ACP1;PTPRE;PTPN2;PGP;PTP4A3;DUSP11;PTPDC1;CDC25B;PTPN13;PTP4A2;DUSP3;PTPN11
prerank,GTPase activity (GO:0003924),0.2950012801079951,0.9143576255560928,0.6715176715176715,0.9369227080587692,1.0,46/192,19.24%,RAB17;MRAS;RAP1B;EEF1A1;RAP1A;RHOQ;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;BMS1;RAB35;GNAO1;AGAP3;GNAQ;GNA13;RHOA;RABL3;OPA1;SEPTIN9;RHOU;RAB5C;RAB1B;HRAS;GNG5;DNM1L;ATL2;GNA11;GPN1;ARHGDIB;RAP2C;RAB33B;ARL8A;EEF2;DIRAS2;RAP1GAP;RAB8B;HBS1L;RNF112;RAB27A;RAB9A;RHOT2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3207351570055186,0.9140660622454749,0.5959952885747939,0.9345098230318671,1.0,13/69,13.91%,SOAT1;EP300;DGAT1;MOGAT3;ZDHHC12;MOGAT1;KAT6B;SOAT2;CERS2;MBOAT7;NAA15;LPCAT3;NAA10
prerank,retinoic acid receptor binding (GO:0042974),-0.335825906123868,-0.91374393143075,0.5877192982456141,0.8839900987247759,1.0,3/17,9.23%,TACC1;NSD1;PPARG
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3127451802926836,0.9135212687944917,0.608548931383577,0.932646300152069,1.0,16/91,10.89%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;TWF1;AVIL;ANXA2;KRIT1;JPH2;RAB35;GSDME;SNX18
prerank,phosphotyrosine residue binding (GO:0001784),-0.2663251608738057,-0.9126602346423986,0.623015873015873,0.8799370697075013,1.0,10/37,13.37%,PIK3R1;NCK2;CRKL;SHE;ABL2;PTPN3;GRB2;BCAR3;SHF;PIK3R3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.42164784054976834,0.9099386825608323,0.5632,0.937535633745966,1.0,8/12,26.84%,SDHB;FDX1;ISCA1;CIAPIN1;ISCA2;AOX1;CISD2;CISD1
prerank,ATPase regulator activity (GO:0060590),-0.26253575198021006,-0.9085690723635667,0.6336206896551724,0.8832315765860406,1.0,16/38,24.18%,TSC1;ATP1B1;DNAJB4;FNIP1;DNAJA1;DNAJC19;FNIP2;BAG4;DNAJB2;BAG5;BRSK2;GRPEL1;DNAJC1;BAG2;DNAJB1;AHSA1
prerank,snoRNA binding (GO:0030515),0.3581518903800179,0.9082987722796199,0.5661664392905866,0.9379654394819534,1.0,6/30,18.25%,NUDT4;BMS1;GAR1;RRP9;IMP4;IMP3
prerank,microtubule plus-end binding (GO:0051010),0.3846591658210464,0.9061228074765925,0.5637982195845698,0.9395647342079766,1.0,3/20,10.55%,MAPRE2;CLIP4;PAFAH1B1
prerank,kinase binding (GO:0019900),0.2802233795638779,0.9056254211955221,0.7323943661971831,0.9376195328579767,1.0,107/434,20.10%,MYOM2;UTRN;ANK2;DAXX;PIK3IP1;CDKN1A;ADAM10;EMP2;GSN;CAV1;MAVS;NBEAL2;EEF1A1;QARS1;FOXO3;RELB;AP2A2;HSPB1;PPP1R15A;PIH1D1;CAV2;BCL2L1;POLR2A;RNF138;FOXM1;SPRED3;SHC1;PFKFB2;MSN;CCND2;SYN1;TRIM21;BAD;ILK;LATS1;SRCIN1;ADCY6;PKD1;FZD5;LRBA;TCF7L2;IQGAP1;OXSR1;CDC42;ACSL3;FBXO5;CHP1;CDK5RAP1;ACTB;PTPN6;CCND1;SMCR8;ZC3HC1;CARD16;EXOC2;MVP;AP2A1;SLC12A4;RHOA;YWHAZ;BCAR1;PPP1CB;JTB;PTPN2;MAPKAP1;KCNA5;PTN;MAP3K13;VDAC1;IRAK1;SHC2;GSK3B;WNK1;DNAJC3;TNNI3;RB1CC1;ITGB2;FLNA;EEF2;FAM83H;AP1B1;CRK;ARHGAP33;PRKAG1;NSF;CDC25B;STUB1;MTCP1;CHEK2;DUSP3;PTPN11;CAMK2N1;SUFU;PARK7;ATF2;MOB1B;CDKN2D;CAB39;CDK5RAP3;IRAK4;SIKE1;TOM1L2;MAP3K1;RB1;PRKAB1;USF1;MAPT
prerank,tau-protein kinase activity (GO:0050321),-0.3051042611610375,-0.9038188089227503,0.632258064516129,0.8880601227192838,1.0,4/20,7.58%,MARK1;BRSK1;PRKAA1;ROCK1
prerank,phosphatidylinositol binding (GO:0035091),0.30548420603877624,0.9035328554044354,0.6317567567567568,0.9391460369692217,1.0,16/91,14.68%,PITPNM2;ITPR2;PIGU;SNX8;PITPNC1;RUBCNL;WDFY3;GPAA1;RUBCN;ITPR3;BCAS3;SNX12;ESYT2;EXOC8;CCDC88A;SNX16
prerank,ion channel activity (GO:0005216),0.30814688832142095,0.9027851222761102,0.6139747995418099,0.9378173212271265,1.0,13/80,13.39%,TRPM3;NALCN;TRPM8;TMC6;MCUB;CALHM5;GRID1;TMC2;TRPM6;TRPM4;PKD2L1;CNGB1;TRPM2
prerank,ATPase binding (GO:0051117),0.3136624099726278,0.9020215201693369,0.6251468860164512,0.9364812581418421,1.0,13/71,14.49%,ANK2;ANK1;PEX26;BBC3;CAV1;PIH1D1;CHMP4A;EZR;ATP5IF1;S100A1;TOR1AIP1;DNAJC10;ATP6V1E1
prerank,metal ion binding (GO:0046872),0.28116293996404446,0.9019959361840987,0.7706237424547284,0.9335555826929378,1.0,56/477,11.73%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;MAP3K5;TSSK6;TSSK4;ANXA8;ANXA8L1;GSN;S100A6;FEN1;EYA2;S100A10;OTOF;IDH3G;PITPNM3;ANXA4;LTBP4;S100A11;ANXA5;FBLN1;RHEB;NT5C3A;SIK3;ANXA2;DCTPP1;MICU1;DSC3;DSC2;LATS1;HPGDS;CETN3;IQGAP1;OXSR1;CALR3;CHP1;PCLO;TRIM26;MOV10L1;PCDHA4;THG1L;ITPR3;DNASE1L2;SRPK2;NDUFAB1;S100A1;TRPM4;PKD2L1;LETM1;CALU;PLSCR3;CDH4
prerank,adenyl ribonucleotide binding (GO:0032559),0.2799557726346693,0.8986625379704953,0.7028397565922921,0.93750445771526,1.0,91/291,22.84%,PRAG1;MAP3K5;MPPED2;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HMGCR;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;HSPA14;LMTK2;MOV10L1;THG1L;AARS1;AK6;SRPK2;MTREX;ABCA2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;SARS2;EIF4G1;TRNT1;WNK1;CDC42BPA;ABCB9;DHX9;HSP90AA1;OAS2;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;PRKAG1;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;SLC19A1;DARS2;ABCB6;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;ATP1A3;ATP1A1;WNK4;MIEF1;YARS2;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1;APRT;ABCB8
prerank,U6 snRNA binding (GO:0017070),0.40710158224932674,0.8972549580175978,0.579454253611557,0.9374630852528886,1.0,5/14,21.21%,LARP7;LSM4;DDX39B;TUT1;PRPF8
prerank,ubiquitin protein ligase activity (GO:0061630),0.28629974092894866,0.8966457547624668,0.6915113871635611,0.9358389540616299,1.0,45/228,17.78%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;CBLL1;TRIM41;TRIM21;RBX1;CDC42;TRIM26;TRIM11;RNF121;LTN1;PPP1R11;SIAH3;COP1;VPS11;RNF126;DTX3;PELI1;VPS18;UBE4A;BRAP;UBR5;NEDD4;MDM2;BFAR;MSL2;PRPF19;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;PDZRN3;TRIM37
prerank,alpha-actinin binding (GO:0051393),0.37021598406101003,0.8964402533366407,0.6182634730538922,0.9332974693485554,1.0,10/24,18.64%,PDLIM5;DAG1;MYOT;PKD2L1;KCNA5;PDLIM7;NRAP;PDLIM3;RARA;PDLIM4
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3596747516272419,0.896024489489792,0.5882352941176471,0.931169028694591,1.0,9/27,18.69%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,cation channel activity (GO:0005261),0.29981436363556224,0.8951704930556617,0.6227477477477478,0.9298889984224772,1.0,18/94,15.70%,TRPM3;NALCN;TRPM8;MCU;CALHM5;ABCC8;ANXA2;PKD1;TRPM6;AQP1;TRPM4;PKD2L1;ANO6;CACNB2;TRPM2;TMEM175;HVCN1;TMEM63B
prerank,histone deacetylase binding (GO:0042826),0.3061336592664091,0.8936997411429577,0.6224256292906178,0.9298965871936389,1.0,20/88,17.34%,GLI3;HDAC5;HDAC4;NACC1;LCOR;MEF2D;YWHAB;FOXP3;CCND1;HDAC3;SP2;NCOR1;MEF2B;SP1;MIER2;MEF2C;NCOR2;HSP90AA1;CAMTA2;HDAC6
prerank,filamin binding (GO:0031005),0.43139311717118595,0.8936314887819411,0.5971563981042654,0.9271252401147723,1.0,1/11,1.59%,NEBL
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4027078765453085,0.8910855555824275,0.5958702064896755,0.9294979160993574,1.0,3/14,18.60%,CAPN2;CAPNS1;CAPN15
prerank,AMP binding (GO:0016208),0.41674947797633677,0.8907199094681075,0.5887372013651877,0.9273650304156479,1.0,2/11,5.22%,MPPED2;PFKP
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.35484811608425826,0.8884523478952472,0.6008344923504868,0.9290675882289638,1.0,9/27,18.69%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,mechanosensitive ion channel activity (GO:0008381),0.4127668406069503,0.8863162057181742,0.6009389671361502,0.9303771477358043,1.0,4/12,21.00%,TMC6;TMC2;TMEM63B;TMC4
prerank,tRNA methyltransferase activity (GO:0008175),-0.32245285725576434,-0.8846239949881514,0.6392572944297082,0.9263558021647101,1.0,8/16,24.67%,TARBP1;THUMPD2;TRMT5;TRMT9B;TRMT44;ALKBH8;TYW3;BCDIN3D
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2735865566365051,0.8808951994873269,0.786144578313253,0.9383898748027536,1.0,121/431,22.53%,PRAG1;MAP3K5;TSSK6;TSSK4;MRAS;RAP1B;ABCD1;ATP1A2;EEF1A1;CDK6;RAP1A;MKNK2;ARL4A;DAPK3;DAPK1;ARL3;HARS1;RHOQ;PFKP;CARS2;TWF1;PMVK;EIF2B2;NRAS;KRAS;RHEB;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;CDC42;RAB7A;HSPA14;ARHGEF5;LMTK2;MOV10L1;GTPBP10;THG1L;AARS1;AK6;BMS1;RAB35;SRPK2;MTREX;ABCA2;PDK2;ARFIP2;RHOA;RABL3;MARK4;SRPK1;OLA1;ARF4;RHOU;TARS1;TUBB2B;VPS4A;SARS2;RAB1B;HRAS;EIF4G1;TRNT1;WNK1;ATL2;CDC42BPA;ABCB9;DHX9;HSP90AA1;RAP2C;OAS2;ARL8A;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;ADSS2;PRKAG1;DIRAS2;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;RNF112;DARS2;ABCB6;RAB27A;RAB9A;RHOT2;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;RAB10;ATP1A3;ATP1A1;WNK4;YARS2;RABL6;RHOC;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.35822102937916744,-0.8787071620395083,0.6234096692111959,0.9335719587732887,1.0,1/11,2.67%,CXCL12
prerank,mannose binding (GO:0005537),-0.357000589330823,-0.8783222731757572,0.6239782016348774,0.9277249498208375,1.0,2/12,12.44%,LMAN2L;LMAN2
prerank,protein phosphatase 1 binding (GO:0008157),0.370270918666331,0.8781503999576338,0.6134094151212554,0.9409638667016582,1.0,4/21,10.21%,SH3RF2;PPP1R15A;PPP1R16A;PPP1R11
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3495203891967191,0.8775452410053614,0.6316489361702128,0.9392888964528995,1.0,7/32,13.71%,SLC36A3;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;SLC6A7
prerank,sodium channel activity (GO:0005272),0.33853139700105483,0.8772483249747554,0.6071428571428571,0.9370301070185486,1.0,2/37,1.20%,ASIC5;SCN3A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2855327410367313,0.876653506041235,0.6927899686520376,0.935347169015842,1.0,28/173,14.17%,TFAP2C;SREBF2;RORC;FOXP2;KLF12;FOXP4;ZNF436;ZNF692;FOXO3;ZNF219;ZBTB16;NACC1;OVOL2;PATZ1;ZBTB17;CC2D1A;ZFHX3;JUN;ZFP57;FOXP3;SP2;ZNF148;MAFK;FOXK1;GATA3;MYC;ZNF177;FOXP1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.43735170412569335,0.8765737014626852,0.6104347826086957,0.9327082744200007,1.0,3/10,18.87%,CDKN1A;HEXIM1;CDKN2D
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.40134591127240876,0.8746429174004963,0.6028708133971292,0.9336584305039507,1.0,5/14,21.40%,SDHB;ACO2;CIAO3;ISCA2;ACO1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.3670680882546607,-0.873429563431879,0.6293333333333333,0.9318194915895835,1.0,4/10,14.80%,PIK3CB;PIK3CD;PIK3R3;PIK3C3
prerank,transcription cis-regulatory region binding (GO:0000976),0.2736863895929057,0.872687989467815,0.8046092184368737,0.9344873227351124,1.0,66/406,16.70%,BNC2;FOXN3;KLF4;TFAP2C;PBX1;TFAP2D;SMAD6;GLI3;GABPB1;GABPB2;ZNF436;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;ZBTB8A;ESRRB;JUND;ZBTB46;FOXM1;ZBTB17;RXRB;SOX9;ZBTB7B;MEF2D;CIC;SIX1;JUN;TCF7L2;CRY2;ZFP57;XRN2;GRHL2;BRD7;NFYC;TWIST1;ARID4A;CREB3;NCOR1;DR1;CALCOCO1;MMP12;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3;RREB1;MYC;ZNF177;MEF2C;FOXP1;IRF2;ATMIN;RFXAP;ZFP3;ACTN4;CDC5L;CREB3L2;RNF10;E2F1;HINFP
prerank,Tat protein binding (GO:0030957),0.4255662500240427,0.8724912403869924,0.6188034188034188,0.9320932230479141,1.0,3/10,11.01%,SMARCB1;ACTB;SMARCA4
prerank,cyclic nucleotide binding (GO:0030551),0.36430474392083073,0.8719374780884237,0.6096866096866097,0.9302849117657792,1.0,3/21,7.35%,PDE5A;CNGA2;CNGB3
prerank,muscle alpha-actinin binding (GO:0051371),0.39465640433813776,0.8714937292951098,0.6266447368421053,0.9283874230910222,1.0,7/15,20.69%,PDLIM5;PKD2L1;PDLIM7;NRAP;PDLIM3;PDLIM4;MYPN
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.33743858969455015,0.870884131734765,0.624484181568088,0.9268701713128444,1.0,6/28,14.48%,FEN1;POP4;POP1;DBR1;RPP21;ENDOV
prerank,NAD+ binding (GO:0070403),-0.345127562506368,-0.8693074475095774,0.6089238845144357,0.9343586037263566,1.0,3/12,15.80%,ZC3HAV1;HPGD;SIRT2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.29436606310262303,0.8692252823123251,0.6892341842397336,0.9270906577036182,1.0,14/100,8.45%,ARAP1;OGT;VEPH1;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;RUBCNL;GOLPH3;ZFYVE19;JPH2;RUBCN;IQGAP1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4037924707247284,0.8668618521440504,0.6132231404958678,0.9288414201573326,1.0,2/12,7.81%,ARSI;ARSB
prerank,NADP binding (GO:0050661),0.3446625047936008,0.8663938032893439,0.6181575433911882,0.9270429254373588,1.0,5/32,8.16%,DHCR7;HMGCR;ME3;CRYZL1;PGD
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.29130453251531985,-0.866167089435695,0.6818181818181818,0.9347629242643425,1.0,6/24,12.00%,PLA2G4A;DAB2IP;PLEKHA8;GSDMD;LANCL2;PLEKHF1
prerank,magnesium ion binding (GO:0000287),0.28244147303452294,0.8650192776913298,0.7108695652173913,0.9268759778921801,1.0,28/135,16.93%,MAP3K5;TSSK6;TSSK4;FEN1;EYA2;IDH3G;RHEB;NT5C3A;SIK3;DCTPP1;LATS1;HPGDS;OXSR1;MOV10L1;THG1L;SRPK2;PLSCR3;SRPK1;OPA1;PGP;ENDOV;CDC42BPA;FAN1;IDH3A;PI4K2A;ABL1;YDJC;MAP3K6
prerank,endopeptidase activator activity (GO:0061133),-0.36103157099464944,-0.8636534150524157,0.631578947368421,0.9340945448907294,1.0,5/10,33.21%,PSME1;APH1B;VSIR;PSME2;NLRC4
prerank,nucleotidyltransferase activity (GO:0016779),0.36426839899935753,0.8618185971424278,0.6376360808709176,0.9301129906540335,1.0,5/19,12.98%,MOCS3;REV1;TENT4A;THG1L;TUT7
prerank,chloride channel activity (GO:0005254),0.30709928106068607,0.8610209747189957,0.6766169154228856,0.9288962872517166,1.0,9/59,15.63%,CFTR;ANO7;CLIC1;CLCN4;SLC1A4;ANO6;ANO3;CLCC1;PACC1
prerank,cation:chloride symporter activity (GO:0015377),0.4156128215380519,0.8606643126722057,0.6288,0.9267998944766319,1.0,3/10,16.21%,SLC12A8;SLC12A4;SLC12A6
prerank,protein tyrosine kinase activator activity (GO:0030296),0.36584687620215284,0.8596103363045552,0.6411042944785276,0.9260146519478206,1.0,4/19,10.17%,CCL5;EFNA5;ERBB3;ABI1
prerank,ribonuclease P RNA binding (GO:0033204),0.4058225698781184,0.8590356675261385,0.6176470588235294,0.9243094986820505,1.0,3/10,12.36%,POP4;POP1;RPP21
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4101003092574259,0.8587765767321972,0.6396694214876033,0.9221816794858024,1.0,2/10,3.47%,CACNA1A;CACNB3
prerank,poly-purine tract binding (GO:0070717),0.3466685524411466,0.8586224646734986,0.6239067055393586,0.9198248865330289,1.0,4/27,6.96%,PABPC4L;PABPC1L;EIF4A3;RBMS3
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4071414658838022,0.85857451084254,0.6306156405990017,0.9173004811049307,1.0,2/12,5.41%,CDK6;CDK4
prerank,MHC class II protein complex binding (GO:0023026),0.41198321708201646,0.8583208274186273,0.6254180602006689,0.9151655769199886,1.0,2/11,6.07%,CD81;PKM
prerank,transcription coactivator binding (GO:0001223),0.3659165813922202,0.8563324829967237,0.6466973886328725,0.9162239845915341,1.0,2/20,6.14%,THRB;ZBTB17
prerank,adenylyltransferase activity (GO:0070566),-0.28686679389331793,-0.8561228093049171,0.6735294117647059,0.9443414300869595,1.0,6/21,20.09%,GPHN;PAPOLA;PAPOLG;SELENOO;TENT2;PAPOLB
prerank,cysteine-type peptidase activity (GO:0008234),0.29860873625990997,0.8559394064649165,0.6920415224913494,0.9143117382148382,1.0,27/73,24.45%,TINAGL1;USP46;USP29;USP10;CTSZ;OTUD7B;CAPN2;USP20;USP24;USP42;SFRP1;USP28;CTSH;ATG4B;USP25;OTULIN;USP21;USP16;CTSK;USP2;USP11;BLMH;CASP3;ATG4D;USP13;USP34;CTSF
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.3283455908176056,-0.8557087935997867,0.6758104738154613,0.9388142851986848,1.0,3/14,12.35%,NOD1;MAL;RACK1
prerank,clathrin adaptor activity (GO:0035615),-0.3161466329445355,-0.853797030831355,0.6685082872928176,0.9368374665322319,1.0,4/15,12.53%,HIP1;DAB2;AP2B1;STON2
prerank,chemokine receptor binding (GO:0042379),0.33074532017315045,0.8532721071982575,0.6596026490066225,0.9166923187377963,1.0,2/35,5.94%,CCL5;CCRL2
prerank,mRNA 5'-UTR binding (GO:0048027),0.3560336290534976,0.8529553342109346,0.6415362731152204,0.9146110009955458,1.0,11/24,28.54%,UTP23;SHMT1;SYNCRIP;IGF2BP3;IGF2BP2;RPL41;IGF2BP1;RPL26;CCT5;LARP1;DDX3X
prerank,fatty acid synthase activity (GO:0004312),0.411398316310999,0.8520086974964237,0.6097560975609756,0.9137372726051499,1.0,2/10,8.13%,ELOVL1;ELOVL6
prerank,peptidase activator activity (GO:0016504),0.360121785654119,0.850920099547006,0.6468842729970327,0.9129821373270313,1.0,2/22,5.01%,CAV1;PCOLCE2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3348477040155014,0.8473366596910472,0.6612466124661247,0.9168527548345909,1.0,11/29,22.76%,DUSP10;DUSP1;MAPK7;PPM1D;TNIP1;ABL1;PRMT1;MAPKAPK2;CDK5RAP3;DUSP16;TPR
prerank,DNA-binding transcription factor binding (GO:0140297),0.26837791431122127,0.8465395943428817,0.7478991596638656,0.9157621941521132,1.0,46/189,19.97%,KLF4;EP300;HDAC5;FOS;DAPK3;CGGBP1;HDAC4;NFE2L2;WWP2;HSPB1;MTDH;CREB1;ZBTB17;HCFC1;DDRGK1;MEF2D;FIZ1;JUN;TCF7L2;TWIST1;TLE2;PTMA;NCOR1;TLE4;YWHAZ;SP1;MIER2;PIAS1;PIAS3;MKKS;MYC;MEF2C;TLE5;GSK3B;DHX9;KDM1A;RERE;NBN;PARK7;ATF2;TLE6;ZBTB7A;RB1;TBP;USF1;DDX20
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3560469797130872,0.8449886456866285,0.6563467492260062,0.9159731203447239,1.0,5/21,14.42%,REV1;POLK;POLG;POLE4;POLH
prerank,calcium channel activity (GO:0005262),0.28196192200417136,0.8443747604403763,0.6977829638273045,0.9145591340338198,1.0,14/84,13.39%,STIM2;CACNA2D3;CACNA1A;TRPM8;MCU;CACNB3;CACNA2D4;ANXA2;TMC2;PKD1;TRPM4;PKD2L1;CACNB2;TRPM2
prerank,ephrin receptor binding (GO:0046875),0.35880878267202854,0.8432329830288801,0.6618287373004355,0.9139379579557618,1.0,6/21,16.81%,EFNB2;EFNA5;SHC1;EFNA4;CRK;ABL1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.24977530614143043,-0.8383846578855982,0.7137404580152672,0.9626242969164739,1.0,5/31,5.23%,KCNK5;ABCC9;PKD2;SLC12A2;KCNQ4
prerank,ADP binding (GO:0043531),-0.26827696370793436,-0.8355960123528687,0.7054794520547946,0.9621874766181919,1.0,2/25,2.14%,PRKAG2;ME1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.30153080957954925,-0.8329159698666156,0.7097701149425287,0.9612069674849583,1.0,9/16,38.88%,SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4;SLC7A8
prerank,voltage-gated calcium channel activity (GO:0005245),0.3084252335945606,0.8322019192995961,0.6688918558077437,0.9306468358696088,1.0,5/37,7.73%,CACNA2D3;CACNA1A;CACNB3;CACNA2D4;TMC2
prerank,GTPase regulator activity (GO:0030695),0.2641479686788748,0.8278964236330772,0.7940267765190525,0.9354581757969682,1.0,44/212,15.22%,ARHGAP42;SRGAP2;ARAP1;RANBP3L;ASAP2;CPEB2;SIPA1L1;ARHGAP18;WNT11;GRTP1;TBC1D16;ADAP1;IPO7;SH3BP4;TSC2;ARHGAP29;ARHGAP10;KRIT1;JUN;IQGAP1;BCR;RALGDS;OPHN1;LLGL2;DLC1;SGSM2;GNAQ;TBC1D1;RASA1;RGS6;DOCK1;ASAP3;ARHGEF10L;OCRL;ARHGAP31;ARFGEF1;PREB;CCDC88A;ARHGAP27;DNM1L;FLCN;ITGB1BP1;SEC23A;USP6NL
prerank,DNA polymerase activity (GO:0034061),0.34470727009285446,0.8277701942574535,0.6702290076335878,0.9331274448638566,1.0,5/22,14.42%,REV1;POLK;POLG;POLE4;POLH
prerank,microtubule minus-end binding (GO:0051011),-0.3249556212107821,-0.8272598441319517,0.7032085561497327,0.9662979721093178,1.0,7/13,29.33%,TUBGCP2;MACF1;CAMSAP2;HAUS4;HAUS7;TUBGCP3;CAMSAP3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.34480740661333,-0.8254785448400132,0.707196029776675,0.9636563891252339,1.0,2/11,5.73%,SGMS1;PTDSS1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.30379901280349114,0.8251602654719905,0.6994884910485933,0.9351002561329036,1.0,11/49,15.27%,ANXA3;ANXA8;ANXA4;ANXA5;ANXA2;PCLO;ESYT2;CPNE2;SYT6;SYT11;SYT12
prerank,histone methyltransferase binding (GO:1990226),0.4000815993922886,0.8249257522392806,0.7020602218700476,0.933015201107824,1.0,2/11,6.01%,PHF1;LCOR
prerank,vitamin D receptor binding (GO:0042809),0.37300844728717203,0.8240533955833439,0.6599063962558502,0.9319208927210502,1.0,3/14,13.64%,MED30;MED12;MED24
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.36615672972581015,0.8238532703576434,0.6533546325878594,0.9297483606567721,1.0,5/14,21.57%,POP4;POP1;RPP21;TSEN2;RPP40
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2578953634184497,0.8204024452417209,0.846309403437816,0.9328143129274991,1.0,101/346,25.37%,RNF152;TRIM60;FBXW8;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;KLHL21;MUL1;CBLL1;TRIM41;TRIM21;MAGEL2;UBE2G2;RMND5B;RBX1;CDC42;RNF146;PML;TRIM47;TRIM26;TRIM11;RNF121;UBE2B;RNF182;LTN1;PPP1R11;SIAH3;COP1;UBE2Q1;VPS11;KLHL13;RNF126;MIB2;RNF123;RNF141;ANAPC4;DTX3;PELI1;VPS18;BRAP;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;UBE2N;MSL2;PRPF19;MAEA;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;UBE2J1;PDZRN3;TRIM37;RNF112;RNF41;RNF130;UBE2Z;UBE3C;FBXO9;RMND5A;ZFP91;CHFR;CUL2;TRIM5;UBE2E1;FBXW2;RCHY1;ARIH2;TRAF3IP2;SMURF2;RNF168;NSMCE1;RNF213;TRIM3;RNF14;RNF7;CDC23;FBXO4;UBR4;UBE3D;RNF150;BIRC3;UBA7;TMEM129;RING1;UBE2M;LRSAM1;TRIM39;TSPAN17
prerank,acid-thiol ligase activity (GO:0016878),-0.312849984547772,-0.8197386187750391,0.696236559139785,0.968438698297278,1.0,3/13,10.90%,ACSS3;ACSL1;ACSS1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3637641630101136,0.8167509392104957,0.6651162790697674,0.9364269584219507,1.0,1/14,2.95%,ADH7
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2924828011872553,0.8165115377391171,0.7109471094710947,0.9343636344247188,1.0,23/54,30.47%,PDF;HDAC5;HDAC4;HDAC3;NIT1;MIER2;NTAQ1;VNN1;HDAC6;ACR;NADSYN1;SIRT4;SIRT7;NGLY1;HDAC8;PM20D1;SUDS3;NTAN1;ASRGL1;ASAH1;HINT3;HDAC11;FAAH
prerank,CARD domain binding (GO:0050700),-0.30908125726794833,-0.8128826037544655,0.7450980392156863,0.9752205648892348,1.0,4/14,11.65%,NOD1;CARD10;IRGM;CASP4
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3519705658932443,0.8119798152893378,0.6998535871156661,0.9393837617122107,1.0,4/18,14.16%,SMAD6;TGFB2;TGFBR2;TGFBR3
prerank,DNA binding (GO:0003677),0.2529578030837442,0.8117510404129428,0.952,0.937244125344926,1.0,165/694,22.46%,NFATC2;THRB;TFAP2C;PPARGC1A;PBX1;ZIC4;FOXP2;NUPR1;ZC3H12A;KLF12;FEN1;SLPI;EP300;MLH1;FOXO3;FOXC2;ZNF219;CGGBP1;SHOC1;HDAC4;NFE2L2;NR6A1;ZBTB16;ZMYM6;POLR2H;SMARCB1;FOXD2;POU2F3;NABP2;ESRRB;RARG;IRF3;SLTM;NKX2-8;PATZ1;PHF1;POLR2A;RNF138;HOXA5;SYCP2;MRE11;SOX9;FOXD1;ZIC2;CENPS;ANG;TSNAX;SIX1;JUN;POU3F1;TCF7L2;CRY2;GRHL2;FOXP3;SDE2;NR2C1;TRIM26;DNMT3A;HDGFL3;ILF2;NFIB;POLG;DNASE1L2;NFYC;CR2;ARID4A;SMARCA4;ARID3B;JRKL;GTF3C3;CALCOCO1;MMP12;SP1;ZNF148;MAFK;ZMYM4;ERCC5;CHD3;GATA3;HMGN1;MBD4;MYC;POLR3C;RPA3;DNASE1L1;REXO4;PAX3;SRRT;IRF2;ENDOV;DNTTIP1;APTX;DHX9;TET1;MCM8;HMBOX1;PCNA;FAN1;CDC5L;ZGPAT;DCLRE1C;GTF3C2;DDB1;MCM6;E2F1;POU4F1;HINFP;ERCC2;SPTY2D1;ABL1;CAMTA2;SMC6;NBN;BCLAF3;MCM7;GTF3C5;TRIM16;TSG101;PLAGL2;MEOX2;RAD50;PARK7;RFC1;ZKSCAN3;RPL6;JCHAIN;APP;KLF2;HDGF;PNKP;ZBTB7A;PCBP2;NUCKS1;ERCC4;TEAD1;USF1;SREBF1;MAPT;IKZF1;NABP1;ZBTB32;ZNF513;IRF6;ZBP1;HOXA1;SNAPC3;ACR;TWNK;ZNF8;MTF1;YY1;SFPQ;TAF6;YBX1;MCM4;ZBTB49;ARNT;LONP1;PGR;MEN1;GTF3C4;RPL7;POLR3F;TFAM;IGHMBP2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.32010899088003175,-0.8083870099636404,0.7116883116883117,0.977220755418826,1.0,4/12,26.86%,SLC2A1;SLC5A3;SLC2A3;SLC2A4
prerank,Toll-like receptor binding (GO:0035325),-0.32898049733350343,-0.8074638338731415,0.7295285359801489,0.9725677465056718,1.0,3/11,13.65%,DAB2IP;TIRAP;UNC93B1
prerank,signal sequence binding (GO:0005048),0.31006387096943594,0.8060350161657711,0.7181571815718157,0.9438565540025539,1.0,10/35,17.56%,KPNA7;NFKBIA;TNPO2;KPNA4;TOMM20;TNPO1;BRAP;RANBP6;IPO4;KPNA1
prerank,ribonuclease P activity (GO:0004526),0.37311310044415186,0.8048882794432463,0.6721581548599671,0.9433097840733861,1.0,3/11,12.36%,POP4;POP1;RPP21
prerank,store-operated calcium channel activity (GO:0015279),0.3957213354213384,0.8045014446001576,0.696763202725724,0.9414105205571957,1.0,1/10,1.25%,STIM2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.25596708145374353,0.8043829676731404,0.8512820512820513,0.9391335509949907,1.0,43/254,15.86%,KLF5;KLF4;TFAP2C;ELF3;FOXO3;FOXC2;GLIS2;ZBTB16;FOXD2;POU2F3;ESRRB;IRF3;NKX2-8;CREB1;HOXA5;ZBTB17;RXRB;SOX9;NRF1;KLF7;SIX1;JUN;GRHL2;PRDM15;NFIB;NFYC;NFIC;CREB3;MEF2B;SP1;GATA3;SMARCD2;RREB1;NFIA;MYC;MEF2C;MYBL1;IRF2;ATMIN;RFXAP;MDM2;KLF6;CDC5L
prerank,transcription coregulator binding (GO:0001221),0.2955588052533793,0.8041098886547117,0.7394636015325671,0.9371768868910022,1.0,5/50,6.14%,THRB;ZBTB16;PHF1;LCOR;ZBTB17
prerank,carboxylic ester hydrolase activity (GO:0052689),0.273330711442346,0.8033260906126207,0.7585034013605442,0.9359732140500346,1.0,7/85,11.30%,PLB1;ABHD5;ABHD15;PLA2G12A;PAFAH2;AARS1;PON3
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3481586888923139,0.8016170234729233,0.6914893617021277,0.9361560253796747,1.0,4/17,16.64%,CMPK1;AK5;AK3;CLP1
prerank,telomerase RNA binding (GO:0070034),0.3314698360493523,0.7992595161747627,0.7122302158273381,0.9374267013202202,1.0,4/22,13.84%,SNRPB;SMG7;GAR1;PINX1
prerank,CoA-ligase activity (GO:0016405),-0.3085885323852401,-0.7987053586991512,0.7463976945244957,0.9823567620197688,1.0,4/14,16.94%,ACSS3;ACSL1;ACSS1;ACSBG1
prerank,3'-5' exonuclease activity (GO:0008408),0.2967041790865122,0.798301476626351,0.7614080834419817,0.936549819719714,1.0,6/45,10.30%,CNOT6;MRE11;XRN2;EXOSC3;ERI3;POLG
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.28655956992018855,0.7918152590199439,0.7611580217129071,0.9442809026010548,1.0,13/53,15.33%,SLC36A3;SLC66A1;OCA2;CTNS;SLC36A4;SLC3A1;SFXN1;SLC25A38;SLC7A6;SLC1A4;SLC6A7;SLC25A12;SLC7A3
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.22045911989735345,-0.7870816810551844,0.8583333333333333,0.9966977510208211,1.0,10/42,13.37%,PIK3R1;NCK2;CRKL;SHE;ABL2;PTPN3;GRB2;BCAR3;SHF;PIK3R3
prerank,glucose transmembrane transporter activity (GO:0005355),-0.28484782544842147,-0.7867610117767856,0.7648809523809523,0.9909156197661508,1.0,5/17,26.86%,SLC2A1;SLC5A3;SLC5A11;SLC2A3;SLC2A4
prerank,chemokine activity (GO:0008009),0.311110087354097,0.7848343173533033,0.760752688172043,0.9526870214437854,1.0,1/31,1.51%,CCL5
prerank,pseudouridine synthase activity (GO:0009982),-0.30489788681806046,-0.7845543907126666,0.7979002624671916,0.98844941890047,1.0,3/13,15.02%,PUS7;DKC1;RPUSD4
prerank,WW domain binding (GO:0050699),0.3221533505629832,0.7845314499326759,0.7312775330396476,0.9507307273095105,1.0,7/26,20.67%,ENAH;WBP1;TCEAL5;TCEAL8;KIF20B;TRAF4;PMEPA1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.32193171329676823,0.7842749560814591,0.7328467153284671,0.9486360940520878,1.0,13/22,31.11%,ATP6V1E1;ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP2C1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.24489552871153047,-0.7819592807918729,0.7794117647058824,0.9865384640055661,1.0,11/27,27.76%,RNF144A;TRAF6;RNF144B;DCUN1D3;PPARA;DCUN1D2;RNF180;SIAH2;FOXL2;RNF19B;DCUN1D4
prerank,MAP kinase activity (GO:0004707),-0.2999130802168133,-0.78123941472242,0.7553191489361702,0.9816359400731761,1.0,2/14,4.32%,MAPK4;MAPK10
prerank,glutathione transferase activity (GO:0004364),0.3264599255141286,0.7812069516389745,0.7407407407407407,0.9510572880292049,1.0,5/23,15.84%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,ribosomal small subunit binding (GO:0043024),0.3453265355533764,0.7791139293025742,0.721183800623053,0.9518519675481039,1.0,2/17,8.91%,CPEB2;EIF4B
prerank,translation elongation factor activity (GO:0003746),0.35212229927833844,0.7773071028688029,0.7292993630573248,0.9520762994041009,1.0,1/14,2.89%,EEF1A1
prerank,hexosaminidase activity (GO:0015929),0.36775571991298184,0.7752696255849202,0.7345276872964169,0.9527579428330093,1.0,4/12,16.26%,HEXA;HEXB;NAGA;HEXD
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3125551826060991,0.7745272902636479,0.735632183908046,0.9514730565956715,1.0,3/25,3.94%,ANXA8;PHLDA3;FCHSD2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.35367143701328607,0.7736998841683124,0.7258805513016845,0.950247613660127,1.0,4/14,14.80%,PYCR3;NOXRED1;ALDH1L2;ALDH1L1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3195101135229177,-0.7735369988245661,0.75,0.9880810010165351,1.0,4/11,24.32%,PRMT3;PRMT9;PRMT6;CARM1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2964051363851399,0.7734967469551622,0.7654155495978552,0.9481837825498031,1.0,11/35,25.84%,NT5C3A;LCMT2;TRPT1;TRIT1;AARS1;DUS2;GATB;DUS3L;FTO;TARS2;FTSJ1
prerank,GTP binding (GO:0005525),0.24932874127154758,0.7701793459206585,0.8730325288562435,0.950924374189389,1.0,32/172,16.92%,MRAS;RAP1B;EEF1A1;RAP1A;ARL4A;ARL3;RHOQ;EIF2B2;NRAS;KRAS;RHEB;GLUD1;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;ARFIP2;RHOA;RABL3;ARF4;RHOU;TUBB2B;RAB1B;HRAS;ATL2;RAP2C;ARL8A;ADSS2;DIRAS2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3566279071536495,0.7696029850867122,0.747163695299838,0.9493794407851472,1.0,2/13,11.95%,ABHD5;LPCAT2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.30733215563242466,0.7674692363267347,0.7554269175108539,0.9501548783762711,1.0,5/27,14.06%,ITPR2;TMEM165;AQP1;SLC41A1;ATP2B4
prerank,cytokine receptor binding (GO:0005126),0.2622523694448078,0.7663610327978374,0.7942528735632184,0.9494258817743878,1.0,10/83,11.60%,CRLF1;CCL5;CLCF1;EPO;CCRL2;PXDN;TGFB2;VEGFB;SOCS2;JAK1
prerank,peptidoglycan binding (GO:0042834),0.37073047986227975,0.7640042564892439,0.7495769881556683,0.9503586722355669,1.0,4/10,19.33%,PGLYRP3;HK1;RNASE7;JCHAIN
prerank,growth factor activity (GO:0008083),-0.20264212906029083,-0.7622958545228856,0.9542857142857143,1.0,1.0,7/74,8.71%,TGFA;JAG1;NRG3;VEGFC;FGF2;IGF2;JAG2
prerank,nucleosomal DNA binding (GO:0031492),0.31761059521008694,0.7616796234612705,0.7492492492492493,0.9515195598720485,1.0,7/21,18.29%,SMARCB1;ACTB;SMARCA4;SMARCD2;GATAD2B;SMARCC1;H3-3A
prerank,single-stranded DNA helicase activity (GO:0017116),-0.2683705427418429,-0.7592075441248186,0.8333333333333334,0.9988495403244804,1.0,12/19,36.90%,WRNIP1;RFC3;HELQ;RAD51;RFC4;RFC2;DNA2;HELB;RFC5;DSCC1;CHTF18;PIF1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.31003227923017745,0.7560305800826485,0.7762237762237763,0.957266214425611,1.0,3/24,9.25%,GLUL;ZDHHC12;GOLGA7
prerank,GTPase inhibitor activity (GO:0005095),0.35176905656504603,0.7547015569749965,0.7428115015974441,0.9568175324275885,1.0,2/13,8.45%,CPEB2;IQGAP1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3077300175948822,-0.7540064217492579,0.7906976744186046,1.0,1.0,7/11,52.94%,CHRNB1;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,gap junction channel activity (GO:0005243),0.30782494254348824,0.7503880796843091,0.7669616519174042,0.9605982673021056,1.0,2/22,5.31%,GJB6;GJC2
prerank,single-stranded DNA binding (GO:0003697),0.25883694337155777,0.7493941312132619,0.8411967779056386,0.9596385433895105,1.0,28/93,22.46%,MLH1;SHOC1;POLR2H;NABP2;RNF138;CRY2;ERCC5;POLR3C;RPA3;REXO4;APTX;DHX9;MCM8;MCM6;POU4F1;SMC6;MCM7;PARK7;JCHAIN;PCBP2;NUCKS1;ERCC4;MAPT;NABP1;TWNK;MCM4;LONP1;IGHMBP2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.29173444258594283,0.7489377364467301,0.8076398362892224,0.9579449865069318,1.0,4/33,9.41%,CNOT6;XRN2;EXOSC3;ERI3
prerank,ion gated channel activity (GO:0022839),0.30620080302627456,0.7479214782454074,0.7456395348837209,0.9569574648976148,1.0,8/24,18.84%,ANO8;ANO7;TRPM4;PKD2L1;ANO6;ANO3;TMEM63B;TTYH3
prerank,aspartic-type peptidase activity (GO:0070001),0.35074799075960844,0.7468320978335802,0.752827140549273,0.9561086308199669,1.0,4/10,23.99%,NAPSA;BACE1;DDI2;PSEN1
prerank,wide pore channel activity (GO:0022829),0.30394280251846595,0.7449063901677792,0.7829232995658466,0.956402504590238,1.0,2/23,5.31%,GJB6;GJC2
prerank,methyl-CpG binding (GO:0008327),-0.24747820372745316,-0.744097488632311,0.8419354838709677,1.0,1.0,7/22,24.46%,MBD2;MECP2;TET3;ZBTB21;MBD3;ZBTB33;ZBTB38
prerank,peptide N-acetyltransferase activity (GO:0034212),0.36932445730127494,0.7420871801909634,0.7615894039735099,0.9580680521168955,1.0,3/10,13.91%,NAA15;NAA20;NAA10
prerank,copper ion binding (GO:0005507),-0.20970626722330762,-0.7397746875794788,0.905982905982906,1.0,1.0,5/42,10.36%,PAM;MOXD1;ATOX1;LOXL3;TP53
prerank,intracellular chloride channel activity (GO:0061778),0.3268168419032328,0.7396567917787296,0.7573415765069552,0.9566778988412743,1.0,5/16,18.84%,ANO8;ANO7;ANO6;ANO3;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3268168419032328,0.7396567917787296,0.7573415765069552,0.9566778988412743,1.0,5/16,18.84%,ANO8;ANO7;ANO6;ANO3;TTYH3
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2841487256464646,0.7383264147399292,0.8235294117647058,0.9561789983199759,1.0,4/34,9.41%,CNOT6;XRN2;EXOSC3;ERI3
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2505588583968753,-0.7346019905453083,0.8280254777070064,1.0,1.0,2/21,5.23%,KL;FGF2
prerank,DNA secondary structure binding (GO:0000217),0.29138777816161165,0.7345106136146821,0.8043184885290149,0.9589657913902396,1.0,10/31,23.68%,RECQL4;KMT2A;ERCC5;MEF2C;ABL1;LIN54;MAPT;YY1;MEN1;FANCM
prerank,hormone activity (GO:0005179),0.26671857137335137,0.7330127377809035,0.8341346153846154,0.958535558078502,1.0,2/54,2.38%,GAL;PENK
prerank,single-stranded RNA binding (GO:0003727),0.27915831053376594,0.7295736578470281,0.8110539845758354,0.9607304616927772,1.0,8/43,15.32%,STRBP;L1TD1;EIF4B;LACTB2;FXR1;ENDOV;ZFR2;DHX9
prerank,endopeptidase regulator activity (GO:0061135),0.28044084147974846,0.7278966432231788,0.8217948717948718,0.9606052159715891,1.0,4/40,11.07%,SLPI;SPINT2;PSMF1;ABCA2
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.2731827811575581,-0.7270215300664584,0.8192771084337349,1.0,1.0,5/15,14.80%,PIK3CB;PIK3CD;PIK3R3;PI4K2B;PIK3C3
prerank,transition metal ion binding (GO:0046914),0.22608562573747326,0.7264141253814643,0.9458917835671342,0.9602287816136407,1.0,87/397,22.22%,NAPEPLD;KLF4;FAM20C;MMP9;GPC1;MPPED2;FEN1;ADH7;TIMM10;EPRS1;ADAM33;GALNT1;HDAC4;LARGE1;TIMP1;RNF5;ALOX5;DUSP12;TIMP2;MGAT1;TES;KDM5C;KLF7;NQO2;TAB3;ANG;MSRB2;CHORDC1;CXXC4;FDX1;KMT2A;PITRM1;SHMT1;PHF5A;KDM3A;ZNF205;LACTB2;SOD2;HEPH;KDM4C;MYT1;PLSCR3;SCD5;MMP12;CHD3;ACO2;NPEPPS;CHMP1A;TARS1;LTA4H;SEC23A;SNCB;MDM2;TET1;ABL1;SIAH1;SLC11A2;TAB2;ZFYVE1;PDXK;PCK2;USP16;PARK7;RNF112;APIP;SEC24B;ENPP5;IDE;TIMM9;ISCA2;ZBTB32;LVRN;TYW5;QPCTL;ACR;ZCCHC4;QPCT;ZNF8;MELTF;ADPRM;DPF3;RASSF1;RCHY1;ARIH2;PHF2;XPNPEP1;AOX1
prerank,DNA polymerase binding (GO:0070182),0.3125900343877491,0.7248915506092001,0.7744360902255639,0.9598162290636393,1.0,6/18,21.79%,NABP2;SMARCA4;HSP90AA1;PCNA;PTGES3;LONP1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2512716693732349,0.7231529979692144,0.8748538011695907,0.9598689941258525,1.0,4/73,8.84%,SORCS2;CRHR2;LGR4;HCRTR1
prerank,carboxylic acid binding (GO:0031406),0.2817891868013071,0.7215476812688344,0.8265440210249672,0.9596927407161172,1.0,4/38,9.13%,RTN4R;SESN2;GLUD1;SHMT1
prerank,solute:sodium symporter activity (GO:0015370),-0.2242308133531125,-0.720295538474218,0.8719723183391004,1.0,1.0,6/27,24.65%,SLC4A10;SLC5A3;SLC5A11;SLC5A7;SLC4A8;SLC5A6
prerank,cardiolipin binding (GO:1901612),0.34068220587807685,0.7190388187718655,0.7779605263157895,0.960719625044123,1.0,3/10,19.87%,GSDME;OPA1;STOML2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.25066132041831646,0.7189824658717026,0.8707482993197279,0.9585094495373461,1.0,23/78,24.45%,USP46;USP29;USP10;CTSZ;CAPN2;GPAA1;CAPNS1;USP20;USP24;USP42;SFRP1;USP28;CTSH;USP25;USP16;CAPN15;CTSK;USP2;USP11;CASP3;USP13;USP34;CTSF
prerank,voltage-gated sodium channel activity (GO:0005248),0.302522100332101,0.7186838692763259,0.8168389955686853,0.956649252264385,1.0,1/22,1.20%,SCN3A
prerank,telomeric DNA binding (GO:0042162),0.27975835082512873,0.7146863680650337,0.8299319727891157,0.9596011059607529,1.0,15/32,31.45%,UPF3A;SMG7;HMBOX1;KDM1A;RAD50;TERF2;TINF2;APEX1;ZBTB48;XRCC5;TERT;TERF1;TERF2IP;NCL;TELO2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.26264680436388,-0.7138790590976812,0.855072463768116,1.0,1.0,4/16,12.24%,MTMR14;MTM1;MTMR7;MTMR2
prerank,ephrin receptor activity (GO:0005003),-0.2605129568216854,-0.7129635444595065,0.8555240793201133,1.0,1.0,6/17,19.19%,EPHA7;EPHB2;EPHB4;EPHA5;EPHB3;EPHA8
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.2605129568216854,-0.7129635444595065,0.8555240793201133,1.0,1.0,6/17,19.19%,EPHA7;EPHB2;EPHB4;EPHA5;EPHB3;EPHA8
prerank,galactosyltransferase activity (GO:0008378),0.3467435504204817,0.7124654385369624,0.81421647819063,0.9601244443127659,1.0,1/11,3.91%,A4GALT
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2859445810069108,-0.7107869686851522,0.8412698412698413,1.0,1.0,2/12,5.29%,VEGFC;DAB2IP
prerank,methylation-dependent protein binding (GO:0140034),-0.1917485135488332,-0.7072440135016547,0.9777777777777777,1.0,1.0,12/57,16.53%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;THAP7;WDR5;ZMYND11
prerank,acetyltransferase activity (GO:0016407),0.28176785276502603,0.7063433554259013,0.8210947930574098,0.9650959392665067,1.0,5/31,13.91%,EP300;KAT6B;PAFAH2;NAA15;NAA10
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2521844719787389,0.7051516535754039,0.8800489596083231,0.9644278254439388,1.0,10/60,12.89%,PPM1L;PPP2CA;PPM1B;DUSP1;UBLCP1;PP2D1;PPM1A;MTMR3;PPP1CB;PPM1D
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3174784279103082,0.7046966679503827,0.819047619047619,0.9627328957071067,1.0,4/15,22.76%,ABHD5;LPCAT2;ABHD4;GPAT3
prerank,four-way junction DNA binding (GO:0000400),-0.2483340969450078,-0.7040302326971144,0.8662613981762918,1.0,1.0,6/17,27.02%,RAD51D;HMGB1;BLM;XRCC2;RAD51B;GEN1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.2410366171693074,-0.7035706549965881,0.8567251461988304,0.9971216012527929,1.0,8/20,23.81%,OTULINL;SENP2;SENP5;OTUB1;USP7;EIF3F;OTUD5;YOD1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.25844380856973365,0.7030201698136759,0.8735632183908046,0.9625028715792909,1.0,14/49,23.60%,MPPED2;ATP1A2;DUSP10;DUSP12;PPP1CB;PGP;PLCXD3;DUSP11;DUSP3;ACP2;DUSP16;ACP6;ARMT1;APEX1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2540719692963192,0.7011237536402792,0.8816120906801007,0.9625595750151601,1.0,9/55,14.06%,ITPR2;MCU;TMEM165;ANXA2;PKD1;PKD2L1;CACNB2;TRPM2;ATP2B4
prerank,ubiquitin-dependent protein binding (GO:0140036),0.33761699323523153,0.7000538998865355,0.8068181818181818,0.9616024310807985,1.0,6/10,32.83%,FAN1;IDE;ANKRD13D;ANKRD13B;USP15;LAPTM5
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.21863109931554714,-0.6996439863577368,0.9133574007220217,0.995752312202084,1.0,8/29,19.24%,PRKAG2;PKIG;CIT;PRKAR2B;SPRED1;INCA1;PRKAR1B;CIB1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.332285763120003,0.6976052922549921,0.8311258278145696,0.9620897562963784,1.0,6/11,29.48%,NABP2;RAD50;TERF2;RPA2;TERF1;TERF2IP
prerank,voltage-gated chloride channel activity (GO:0005247),0.3328807430358267,0.6949408599012225,0.8175895765472313,0.9631376313139299,1.0,2/10,12.23%,CLCN4;ANO6
prerank,3'-5' DNA helicase activity (GO:0043138),0.3064426241218486,0.6852904108865664,0.8306709265175719,0.9721261666358479,1.0,7/16,26.93%,RECQL4;DHX9;MCM6;MCM7;FANCM;FBH1;MCM2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.26447332950218383,-0.6845503852462806,0.9005681818181818,1.0,1.0,4/14,12.24%,MTMR14;MTM1;MTMR7;MTMR2
prerank,transcription corepressor binding (GO:0001222),0.2784473145601666,0.6839038400127625,0.859375,0.9714997332540916,1.0,13/27,27.47%,ZBTB16;PHF1;LCOR;HDAC3;HDAC6;HDGF;ZBTB7A;USP11;PER1;PER2;WIZ;EHMT1;CTBP2
prerank,calcium activated cation channel activity (GO:0005227),0.29194479064476025,0.683094905360141,0.8239095315024233,0.9701559171295165,1.0,7/17,22.94%,TRPM4;PKD2L1;ANO6;TMEM63B;KCNMB2;KCNMB3;ANO10
prerank,ubiquitin binding (GO:0043130),0.23809456313770458,0.6811866769360138,0.8995215311004785,0.970076363165942,1.0,23/73,25.29%,CXCR4;HSPB1;NSFL1C;MARK4;UBXN7;NPLOC4;NEDD4;MDM2;IKBKG;RNF31;UBE2N;USP25;TSG101;USP16;RAE1;ILRUN;FBXW7;RNF168;DDI2;USP13;UBXN2A;NUP62;UBAP1
prerank,N-acetyltransferase activity (GO:0008080),0.29678494792001403,0.6806675263471477,0.8532374100719424,0.9684411014277052,1.0,3/19,13.91%,EP300;AANAT;NAA10
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.26110554328252766,-0.680026334386546,0.8668555240793201,1.0,1.0,4/14,25.53%,KCNJ2;KCNJ8;KCNIP2;KCNJ3
prerank,myosin V binding (GO:0031489),-0.25008233464472274,-0.6796505003154476,0.8970588235294118,0.9998029758234893,1.0,4/15,19.53%,RAB11B;RAB39B;RAB3D;RAB3C
prerank,triglyceride lipase activity (GO:0004806),0.2855382678710929,0.6787900688003795,0.8610709117221418,0.9683951420470122,1.0,1/20,3.17%,ABHD5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3271221798344148,0.6782648165828133,0.8285229202037352,0.9667508455005057,1.0,1/11,6.75%,DDAH2
prerank,kinase activity (GO:0016301),0.2250605756547822,0.6775852166108692,0.9361233480176211,0.9653341343365971,1.0,23/109,17.85%,EPHA4;PIK3C2B;IP6K1;AGK;PMVK;STK39;MAPK15;NADK2;DCAKD;NADK;PPIP5K2;PI4KA;CKMT1A;DGKA;PKMYT1;PSTK;IRAK1;DOLK;GSK3B;IP6K2;ABL1;TRRAP;PDXK
prerank,channel activity (GO:0015267),-0.19236269183165122,-0.6759762847878862,0.9570815450643777,0.9980263474290859,1.0,12/41,28.35%,BCL2;PANX1;AQP11;AQP4;BAX;KCNK3;MPV17;CHRNB1;SLC14A1;TRPA1;TMEM120B;PANX2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.27281727484318935,-0.6752180554385147,0.8686131386861314,0.9933876259454189,1.0,3/11,15.22%,KCNN2;KCNMB4;KCNMA1
prerank,palmitoyltransferase activity (GO:0016409),0.26592963042803464,0.6735560683026237,0.8771929824561403,0.9675480142146229,1.0,3/28,9.25%,GLUL;ZDHHC12;GOLGA7
prerank,anion:anion antiporter activity (GO:0015301),0.29131652757370674,0.6729984807225045,0.8378787878787879,0.9660732739269259,1.0,6/17,25.02%,SLC4A2;SLC26A4;SLC25A4;SLC19A1;SLC25A11;SLC4A3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.271603608014586,0.6721228824559823,0.8631875881523272,0.9647345732990604,1.0,3/28,9.40%,PRKAA2;AURKC;MAP2K2
prerank,histone acetyltransferase binding (GO:0035035),0.28541781138580785,0.6718148451359978,0.863905325443787,0.9629009736245598,1.0,5/21,19.56%,GLI3;FOXP3;BCAS3;PCNA;ZBTB7A
prerank,pyridoxal phosphate binding (GO:0030170),0.28644620742344584,0.6713944699295883,0.8469241773962805,0.9611977468114717,1.0,9/20,31.07%,ABAT;SHMT1;PDXK;PYGB;PYGM;PLPBP;PNPO;OAT;PSAT1
prerank,SUMO binding (GO:0032183),-0.26123100888321643,-0.6693835897685957,0.9112903225806451,0.9933810789979209,1.0,4/13,17.50%,SERBP1;RNF4;SIMC1;USPL1
prerank,protein phosphatase regulator activity (GO:0019888),0.24123730679459993,0.6660546790065051,0.9081885856079405,0.9643358596238004,1.0,14/53,19.18%,PPP6R3;RCAN1;PPP1R15A;PPP2R2D;LGALS3;LMTK2;PPP1R16A;PTN;SET;PPP1R1B;IGBP1;PPP2R2C;PPP2R5E;RCAN2
prerank,phosphatidylglycerol binding (GO:1901611),0.3041363641196864,0.6637539190697113,0.839546191247974,0.9643884188493334,1.0,3/13,12.70%,PITPNC1;GSDME;OPA1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3003995756390946,0.6633227852262171,0.8603174603174604,0.9627042736639343,1.0,2/14,9.99%,CMPK1;AK5
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.2749590585903542,-0.6631831319961997,0.887434554973822,0.9937794607692341,1.0,8/11,53.73%,KCNJ8;KCNJ3;KCND3;KCNE5;KCNQ1;KCNJ5;KCNE2;KCNE3
prerank,symporter activity (GO:0015293),-0.27530271826166963,-0.6628856892476346,0.863517060367454,0.9887861983847493,1.0,3/10,24.65%,MFSD2A;SLC5A5;SLC5A6
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.24824658602474567,0.6586832723787404,0.9027777777777778,0.9650872568035318,1.0,7/42,18.87%,CDKN1A;CCND2;CCND1;CCNL2;HEXIM1;CCNG1;CDKN2D
prerank,DNA replication origin binding (GO:0003688),0.27919100362537724,0.656268433454489,0.8817518248175182,0.9653662595420149,1.0,7/23,21.60%,GRWD1;DHX9;MCM8;MCM6;MCM7;ORC2;MCM4
prerank,protein phosphatase activator activity (GO:0072542),0.30179348528065675,0.6530789195697945,0.8330683624801272,0.9661876045716862,1.0,6/13,30.99%,PPP1R15A;PPP2R5E;CALM2;PHACTR4;CALM1;PPP2R5C
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.24303260203642363,-0.6509750503890213,0.8980716253443526,0.9930695618405896,1.0,1/14,1.56%,SLC26A7
prerank,MHC class I protein binding (GO:0042288),-0.25249416684973014,-0.6478019771234288,0.9189944134078212,0.990335038717179,1.0,2/13,11.59%,TAP2;ATP5F1A
prerank,transaminase activity (GO:0008483),0.30359463934872455,0.6469568044003342,0.8603531300160514,0.9696516052035433,1.0,2/11,16.10%,ABAT;BCAT2
prerank,mannosyltransferase activity (GO:0000030),0.2675786131628851,0.646135659145598,0.8945022288261516,0.9683497374792956,1.0,4/21,13.67%,TMTC1;PIGZ;ALG1;ALG12
prerank,hormone receptor binding (GO:0051427),-0.24382638934275902,-0.6453401926564719,0.9120234604105572,0.9870026622957044,1.0,3/14,13.83%,JAK2;TYK2;PTHLH
prerank,anion transmembrane transporter activity (GO:0008509),0.29861473796757443,0.6423499166117107,0.8842975206611571,0.9695859087787124,1.0,1/12,2.52%,SLC4A2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.25226271365042374,-0.6311229378102559,0.9122807017543859,0.9916756239826833,1.0,5/11,27.37%,HMGA2;APLF;NEIL3;ALKBH1;NTHL1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.2665343837462164,0.6286771335401704,0.8829787234042553,0.9792813008904399,1.0,1/18,2.60%,TNFAIP8
prerank,RNA methyltransferase activity (GO:0008173),-0.21190542340095714,-0.6283069664773753,0.9320987654320988,0.9883921779519705,1.0,6/19,24.67%,METTL8;TRMT5;TRMT9B;TYW3;MRM2;BCDIN3D
prerank,flavin adenine dinucleotide binding (GO:0050660),0.23002940364336438,0.6275441055552666,0.9354037267080745,0.9780731623812432,1.0,11/53,17.84%,MICAL2;CYB5R3;NQO2;ACADL;MICAL1;CRY2;ILVBL;SQLE;PPOX;KDM1A;PRODH
prerank,pentosyltransferase activity (GO:0016763),0.24032525916026637,0.6268872256270268,0.9159001314060446,0.9765003843757862,1.0,8/36,18.27%,LARGE1;PARP3;UPP2;UMPS;PARP6;TNKS2;UPP1;PARP2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.1963798912938525,-0.6254679782566063,0.9816176470588235,0.9850953036326646,1.0,12/29,27.43%,ACER2;GAA;GALC;GBA2;HPSE2;NEU1;CTBS;NEU3;HYAL2;ENGASE;OVGP1;HPSE
prerank,metalloaminopeptidase activity (GO:0070006),-0.22626322953014294,-0.6232070345382549,0.9159420289855073,0.9814075364411902,1.0,5/16,23.20%,MMP16;ENPEP;ANPEP;XPNPEP3;TRHDE
prerank,water transmembrane transporter activity (GO:0005372),0.29970326611396886,0.6227295609500721,0.8769230769230769,0.9777706833967914,1.0,2/11,12.80%,AQP1;PDPN
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.23406106848940625,0.6225650064729653,0.946047678795483,0.9757961638287747,1.0,5/40,11.42%,CARNMT1;GAMT;NNMT;DNMT3A;THUMPD3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.24547236875956796,0.6137458673926155,0.9152777777777777,0.9804430742263867,1.0,4/27,13.62%,ANKH;SLC22A8;SLC25A14;SLC26A4
prerank,cAMP response element binding (GO:0035497),0.29527594300773524,0.6126663861324644,0.8790322580645161,0.9791875720759015,1.0,4/10,18.47%,CREB1;JUN;CREB3L2;ATF2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.2494391675008366,0.6119033512775555,0.9308005427408412,0.9776528789287917,1.0,6/28,21.26%,EDA;FEM1B;PIDD1;TRIM37;TRAF4;TMBIM1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.23756082599368472,0.6102653769950537,0.9331550802139037,0.9767568258316557,1.0,10/34,21.79%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2D3;UBE2F;UBE2J1;UBE2Z;UBE2E1
prerank,phosphatase inhibitor activity (GO:0019212),0.26782223719023524,0.609854075312963,0.9085271317829458,0.9749569464273594,1.0,5/20,15.10%,LGALS3;LMTK2;PTN;SET;PPP1R1B
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.2603297055403936,0.6098477942718454,0.9377777777777778,0.972871370309633,1.0,8/21,26.92%,EZR;AKAP5;WASF1;ARFGEF1;AKAP8;PRKACA;AKAP1;WASF3
prerank,1-phosphatidylinositol binding (GO:0005545),0.27210765001115517,0.6098064721461347,0.9100449775112444,0.9708201658705926,1.0,6/15,26.41%,WDFY3;ZFYVE1;SESTD1;WDFY1;SNX10;EEA1
prerank,RNA polymerase binding (GO:0070063),0.26484542483798645,0.6092057843044757,0.915680473372781,0.9691926516253865,1.0,4/18,15.47%,STOM;NEDD4;DHX9;PABPN1
prerank,NADPH binding (GO:0070402),0.2791406212345797,0.6082501048916163,0.9,0.9678910583276477,1.0,2/13,14.29%,HMGCR;DUS2
prerank,methylated histone binding (GO:0035064),-0.16327107268828922,-0.6055901400632049,0.9940476190476191,0.9866656539583397,1.0,12/62,16.53%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;THAP7;WDR5;ZMYND11
prerank,zinc ion binding (GO:0008270),0.1894643480066702,0.6002581535220052,0.9928861788617886,0.9712474953289185,1.0,60/293,22.04%,NAPEPLD;KLF4;MMP9;ADH7;TIMM10;EPRS1;ADAM33;HDAC4;TIMP1;RNF5;DUSP12;TIMP2;TES;KDM5C;KLF7;NQO2;TAB3;MSRB2;CHORDC1;CXXC4;KMT2A;PITRM1;SHMT1;PHF5A;ZNF205;LACTB2;KDM4C;MYT1;MMP12;CHD3;NPEPPS;CHMP1A;TARS1;LTA4H;SEC23A;MDM2;TET1;SIAH1;TAB2;ZFYVE1;PDXK;USP16;RNF112;APIP;SEC24B;ENPP5;IDE;TIMM9;ZBTB32;LVRN;QPCTL;ACR;ZCCHC4;QPCT;ZNF8;DPF3;RASSF1;RCHY1;ARIH2;PHF2
prerank,voltage-gated cation channel activity (GO:0022843),0.20010185850217627,0.599937226820068,0.9886749716874292,0.969389609634721,1.0,11/97,13.56%,CACNA2D3;CACNA1A;CACNB3;PTK2B;CACNA2D4;TMC2;KCNA4;KCNB1;KCNA5;CACNB2;KCNQ5
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.23002018995502171,0.5967274006386443,0.9407114624505929,0.9694288175464616,1.0,15/33,31.12%,RNF5;DCUN1D5;SIAH3;DCUN1D1;SIAH1;PARK7;ARIH2;RNF14;UBE3D;RPS3;RNF19A;UBA2;TOLLIP;PRKN;ARIH1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.2404702917248306,-0.5940692264673956,0.9496221662468514,0.987701003233694,1.0,2/12,12.35%,NOD1;RACK1
prerank,thioesterase binding (GO:0031996),-0.2382761036506187,-0.5901830143969321,0.9371584699453552,0.9845210691364968,1.0,4/11,21.99%,TRAF6;ARF6;TRAF1;HAUS7
prerank,regulatory RNA binding (GO:0061980),0.22602689046889365,0.5857988644522633,0.9516339869281045,0.9746292613798098,1.0,5/38,15.32%,ZC3H12A;TARBP2;TUT7;RBM10;DHX9
prerank,MHC protein binding (GO:0042287),0.24520563335360612,0.5757027059541693,0.9238505747126436,0.9786309614709916,1.0,3/20,16.20%,CD81;ABCB9;ATP5F1B
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.21524115731495658,-0.5735394938865397,0.954177897574124,0.9869341719741966,1.0,4/14,23.65%,NOX4;NCF2;CYBB;AIFM1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.22401562689598614,0.5683444202778268,0.9648648648648649,0.9807093138800504,1.0,9/31,21.79%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2D3;UBE2J1;UBE2Z;UBE2E1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.21806846723648587,0.5551034178097798,0.9625668449197861,0.9852934646742987,1.0,4/32,13.56%,KCNA4;KCNB1;KCNA5;KCNQ5
prerank,O-methyltransferase activity (GO:0008171),0.2650340641313694,0.5495003677320346,0.9411764705882353,0.9856957351387303,1.0,4/10,25.58%,MEPCE;COQ3;CMTR2;LRTOMT
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.21475806642579792,-0.5474827265943324,0.9751381215469613,0.9919309853347786,1.0,3/12,20.74%,TRAF6;BABAM2;TRAF1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.21104881679874452,0.5473708686423493,0.9680851063829787,0.9845250988737835,1.0,7/35,18.34%,PTK2B;CSK;STYK1;TXK;ABL1;PEAK1;YES1
prerank,peptide hormone receptor binding (GO:0051428),-0.2225848973699077,-0.5462808363792536,0.9775561097256857,0.9874089056588565,1.0,11/11,77.76%,PTHLH;CCK;UCN2;GPHB5;GHRH;GPHA2;UCN3;PSMC5;GNRH1;VIP;ADCYAP1
prerank,P-type ion transporter activity (GO:0015662),-0.20920748395714356,-0.5406325597661705,0.9782608695652174,0.9842683932017219,1.0,1/12,3.59%,ATP2A2
prerank,alpha-tubulin binding (GO:0043014),0.21027983732238478,0.5397029494832223,0.9793956043956044,0.9857795326672041,1.0,15/31,31.18%,EFHC2;WASHC1;ARL8A;HDAC6;TBCE;CDK5R1;TRPV4;ARL8B;FYN;RACGAP1;SNCA;TBCEL;EFHC1;TAOK1;ARL4C
prerank,ubiquitin-specific protease binding (GO:1990381),0.22965043103982685,0.528713727035491,0.963302752293578,0.9881413758899308,1.0,3/19,18.46%,LCOR;RHBDD2;PARK7
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.19529932417745854,-0.5225650867463508,0.9834254143646409,0.9844284469252353,1.0,4/15,21.94%,RBBP5;WDR5;PRDM9;WDR82
prerank,kinesin binding (GO:0019894),0.2096248565631626,0.5194417693092792,0.9777158774373259,0.9895046393989029,1.0,12/27,30.50%,KIF1B;ACTB;TOR1A;CROCC;AP1AR;KLC2;TTBK2;MAPK8IP1;SNCA;MAPK8IP2;AP1G1;SPAG9
prerank,aminopeptidase activity (GO:0004177),0.21080019396257174,0.5169490645215804,0.9772403982930299,0.9882803082181654,1.0,9/26,22.36%,NPEPPS;LTA4H;CTSH;LVRN;MMP14;RNPEPL1;METAP1D;XPNPEP1;BLMH
prerank,miRNA binding (GO:0035198),0.1902129235468782,0.4731764461663888,0.989100817438692,0.9979152325079398,1.0,3/30,13.19%,ZC3H12A;TUT7;RBM10
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.18121916508457164,0.4516603198232312,0.9985915492957746,0.9996921096949902,1.0,4/30,19.48%,TNFAIP8;CARD16;XIAP;UBE2Z
prerank,N-methyltransferase activity (GO:0008170),0.1727971061190034,0.4064077668023135,0.9971590909090909,1.0,1.0,7/20,26.22%,NNMT;PRMT1;ZCCHC4;FDXACB1;N6AMT1;TRMT11;METTL5
prerank,carbohydrate:cation symporter activity (GO:0005402),0.16565187370535428,0.35140415575275086,0.998330550918197,1.0,1.0,11/11,83.45%,SLC2A9;SLC2A10;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC17A5;SLC23A2;SLC23A1;SLC5A11;SLC5A3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.15388093523576943,0.3478772029934962,1.0,1.0,1.0,1/16,6.49%,MACROD1
prerank,phospholipase binding (GO:0043274),0.16152559653203935,0.3462651090316878,1.0,0.9995776624020045,1.0,5/13,30.85%,PAFAH1B1;FYN;PDPK1;PRKN;SYK
